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Abstract 
 
Engineered lung tissue could potentially facilitate tissue augmentation strategies in 
pediatric and adult pulmonary medicine. In addition, engineered lung tissue could 
provide models for in vitro studies on pulmonary cell/developmental biology, 
pathobiology and pharmacology. This thesis describes in vitro engineering of 
organotypic fetal lung tissue by harnessing specific effects of exogenously 
supplemented fibroblast growth factors (FGFs) on embryonic day 17.5 murine fetal 
pulmonary cells (FPC) cultured in 3-D collagen gels. FGF10 and FGF7 promoted 
epithelial proliferation and branching responses, while FGF2 induced mesenchymal 
proliferation and vascular network formation. The cocktail of FGF10/7/2 synergistically 
combined these effects to produce constructs with optimal epithelial growth/branching, 
controlled mesenchymal proliferation, vascular network formation and epithelial-
endothelial interfacing. Loss-of-function studies using a soluble vascular endothelial 
growth factor receptor (sVEGFR) revealed that endogenous VEGF-A is required for 
vascular network formation. Loss-of-function studies were performed targeting 2 
additional molecules known to play key roles in lung development in vivo, the 
extracellular matrix protein tenascin-C (TN-C) and the morphogen sonic hedgehog 
(SHH). Treatment with TN-C neutralizing antibodies, as well as inhibition of SHH 
signaling with cyclopamine, decreased endothelial elongation and interconnectivity, but 
did not completely ablate network formation, as was the case with sVEGFR treatment. 
Interestingly, it was found that exogenous SHH alone induces vascular network 
formation; however, the morphology and secondary sprouting behavior of SHH-induced 
vessels was markedly different than for FGF-induced vessels. These findings 
demonstrate the ability of the tissue engineer to “fine tune” vascular formation in 
engineered tissues in vitro by manipulating multiple morphogenic signaling pathways 
and extracellular matrix. The functionality of nascent vascular structures within 
viii 
engineered fetal lung tissue was tested in 2 in vivo models: the Matrigel plug model 
using freshly isolated FPC, and the renal capsule model using constructs cultured in 
vitro for 1 week. Both studies showed that epithelial structures maintain differentiation in 
vivo, and that donor-derived vascular structures contribute to the establishment of a 
perfused vasculature in vivo. Taken together, the findings of this thesis suggest that in 
vitro engineered lung tissue will provide novel venues for lung biology research and with 
further advances revolutionize pulmonary regenerative medicine.  
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Chapter 1: Introduction 
 
 
1.1 Tissue Engineering and Regenerative Medicine 
 
Despite the emergence and promise of stem cell-based therapies, regeneration and 
replacement of damaged tissues remains a daunting medical challenge. Traditionally, 
tissue engineering has focused on engineering synthetic extracellular matrices to instruct 
cell behavior, with most of the emphasis on developing appropriate biomaterials and 
scaffold geometries. While these biomaterials-based approaches are essential to the 
progress of the field, this thesis focuses on a developmental biology-based approach to 
engineering fetal lung tissues in vitro, with heavy emphasis placed on cell-cell 
interactions and important signaling molecules. Vascularization of engineered tissues 
will be essential to maintain viability and promote integration of potential tissue 
transplants. One of the main goals of this thesis is to gain a greater understanding of 
how to “fine tune” the in vitro development of blood vessel networks within engineered 
tissues. 
 
1.2 Lung Tissue Engineering 
 
The “budding” field of lung tissue engineering has progressed significantly, as evidenced 
by several recent studies on the in vivo and in vitro generation of pulmonary tissue 
constructs (Chen et al., 2005, Mondrinos et al., 2006a, Cortiella et al. 2006, Andrade et 
al. 2006, Mondrinos et al. 2007a). With recent advances in stem cell biology indicating 
the potential of generating lung epithelial lineages (Samadikuchaksaraei et al. 2006), it 
has become increasingly relevant to understand the contributions of specific extracellular 
matrix molecules and growth factors that promote organization of pulmonary tissue in 
engineered systems. Much of the work in the field of lung tissue engineering has 
focused on the comparison of lung cell growth on various scaffolds, with little attention 
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paid to the cell biological aspects such as cell-cell interactions, growth factor biology and 
extracellular matrix production. The goal of this thesis is to go beyond optimizing the 
conditions for tissue assembly, and provide mechanistic insight as to how engineered 
lung tissues assemble in vitro and also to further the current understanding of how such 
tissues may interface with a living animal upon implantation.   
 
1.3 Lung Anatomy and Physiology 
 
 
The adult lung is a vital organ which facilitates respiration and oxygenation of the blood 
and therefore sustenance of life. The lung is an extremely complex organ comprised of 
greater than 40 differentiated cell types in the adult, which are found in 
compartmentalized regions that serve different functions. The main functional 
component of the lung is the epithelium, comprised of the tracheal epithelium (trachea), 
then the bronchial epithelium (conducting airways) and finally the alveolar epithelium 
(terminal respiratory airways) is derived from the endodermal germ layer in the embryo 
(Figure 1, from Hislop 2002). The trachea may be considered a separate organ, and is 
comprised of a simple epithelial tube enrobed with a mesenchymal layer and cartilage to 
maintain an open windpipe. The bronchial region of the region of the lung is composed 
of tubular airways enrobed with smooth muscle that controls tone and thus the amount 
of air conducted down to the respiratory region. The distal lung, which is comprised of 
the respiratory bronchioles, alveolar ducts and finally the alveoli, is where the 
physiological function of blood oxygenation and carbon dioxide release occur. Although 
asthma is major medical problem which targets the conducting airways, most pediatric 
lung pathologies and adult lung diseases including emphysema, are characterized by 
either incomplete development or destruction of the distal alveoli, respectively. The 
pulmonary connective tissue (elasticity) and the vascular system (appropriate interfacing 
for oxygenation) are essential for appropriate lung function, and many lung pathologies 
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result from specific defects in lung interstitium (hyperproliferation, fibrosis) and 
vasculature. 
 
 
Figure 1: Illustration of progressive lung epithelial branching morphogenesis. Taken from 
Hislop 2002. The corresponding timelines for human gestation are on the left.                                                                          
 
 
 
1.4 Embryonic lung development: Mice as a model  
 
The endodermal epithelium of the ventral foregut is induced to become lung by the 
adjacent cardiac via fibroblast growth factor signaling (Serls et al. 2005) and 
subsequently branches into the lung mesenchyme, derived from the mesodermal germ 
layer (Gilbert 2005). In mice (Ten Have-Opbroek 1991), lung development begins at 
embryonic day 9 (E9) when the lung bud arises, and it is divided into four stages (1): 1 - 
Pseudoglandular stage (E12.5-E16), during which the bronchial and respiratory tree 
develops. 2 - Canalicular stage (E16-E17.4) terminal sacs and vascularization develop. 
3 - Terminal sac stage (E17.5-D5): number of terminal sacs and extent of vascularization 
increase; the alveolar type I (AE1) and type II (AE2) cells differentiate. 4 - Alveolar stage 
(postnatal D5-D30): terminal sacs mature into alveolar ducts, sacs and alveoli to 
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complete lung development. The progression of these events in the human lung is 
depicted in Figure 2 below (left panel). As shown in Figure 2, the branching process 
switches from dichotomous branching into a sacculation event combined with branching 
during the development of the distal alveoli, during the saccular stage of lung 
development. The stages of lung development in mice and humans, albeit it on markedly 
different time scales, are very similar, suggesting that mice are an appropriate animal 
model of human lung development, at least for investigating basic cellular processes. 
The terminal alveolar subunit in the adult lung is also shown in Figure 2, the alveolar 
saccule is composed of a squamous epithelium composed of AE1 cells, occasional 
cuboidal AE2 cells, which produce surfactant and act as the distal lung “stem cell”, 
abundant capillaries, and septal myofibroblasts.  
 
 
Figure 2: H & E section of adult mouse alveolus. Labeled are the alveolar space (alveolus), 
capillaries, cuboidal alveolar type II and squamous alveolar type I cells. Taken from 
(http://www.lab.anhb.uwa.edu.au/mb140/CorePages/Respiratory/respir.htm) 
 
fibroblast 
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1.5 Fetal Pulmonary Cells as a Model for Lung Tissue Engineering 
 
 
In vitro generation of tissue constructs requires an appropriate cell source. The 
experiments conducted in this thesis utilize E17.5 murine fetal pulmonary cells (FPC), 
which coincide with the onset of the terminal sac stage (E17.5-D5) during which the 
number of sacs/buds and vascularization increase; and the AE1 and AE2 cells 
differentiate (Ten Have-Opbroek 1991). The initial formation of the distal pulmonary 
vascular plexus has occurred at this point, however there are reports indicating that 
subsequent distal vascular development occurs via a combination of vasculogenesis and 
angiogenesis, although this process is not clearly understood (Parera et al. 2005). Lung 
development is completed during the alveolar stage (postnatal D5-D30), which sprouting 
angiogenesis to facilitate capillary ingrowth into alveolar septa has been shown to be 
required (De Lisser et al. 2005). The topic of lung vascular development and vascular 
development as a general process will be discussed in subsequent chapters. 
 
 
Figure 3: Cartoon representation of alveolar development during the saccular and alveolar 
stages of lung development. Sacculation events create clefts, which are penetrated by 
capillaries, greatly increasing the area of blood-air interface. 
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1.6 Tissue interactions & signals in lung development 
 
The following sections review first tissue interactions known to regulate lung 
development (phenomenology), then provide more detailed information about specific 
signaling pathways and matrix biology relevant to the studies performed in this thesis. 
 
1.6.1 Epithelial-Mesenchymal interactions 
 
 
Seminal experiments in the 1960’s demonstrated that regional-specific mesenchyme 
specifies epithelial differentiation (Alescio and Cassini 1962). In these studies and more 
recent studies by John Shannon and colleagues, it was demonstrated in reciprocal 
recombination experiments that distal lung mesenchyme is capable of inducing 
branching morphogenesis and expression of distal genes in tracheal epithelium taken 
sufficiently early in lung development (Shannon et al. 1998, Shannon and Hyatt 2004, 
Hyatt et al. 2004). Similarly, recombination of distal lung epithelium with tracheal 
mesenchyme leads to a lack of epithelial branching and “distal de-differentiation”, 
indicated by expression of proximal genes (Hyatt et al. 2004).   
 
 
1.6.2 Epithelial-Endothelial Interactions & Mesenchymal-Endothelial Interactions 
 
 
Developmental interactions between lung epithelial and endothelial cells (Hislop 2002) 
have not been studied nearly as extensively as interactions between lung epithelium and 
lung mesenchyme. However, tissue recombination experiments have demonstrated that 
lung epithelium is required for differentiation of distal lung mesenchymal progenitors into 
endothelial cells, suggesting that the epithelium may orchestrate distal pulmonary 
vasculogenesis (Gebb and Shannon 2000). Endothelial cells are required for 
development of the liver (Matsumoto et al. 2001) and pancreas (Lammert et al. 2003), 
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even prior to establishment of perfused vasculature, suggesting an instructive role for 
the endothelial cell in organogenesis of these endoderm-derived tissues. Although such 
a distinct role has not yet been established in lung development, evidence illustrating the 
potential instructive role of vascular development in regulating lung epithelial 
development has been reported in both in vitro (Schwarz et al. 2004) and in vivo 
systems (Zhao et al. 2005). For example, Schwarz et al. reported that ablation of 
endothelial network formation by endothelial-monocyte activating polypeptide (EMAP) II 
inhibited formation of quasi-3D cystic epithelial aggregates (Schwarz et al. 2004). 
Importantly, this study highlighted that EMAP II enhances the expression of fibronectin 
but not laminin, which may indicate that EMAP II inhibits epithelial development via 
alteration in the balance of extracellular matrix molecules, rather than a vascular-derived 
signal. Similarly, in murine embryonic lung allografts transplanted into the renal capsule, 
inhibition of vascular development using soluble VEGFR1 resulted in decreased 
vascular and saccular epithelial development (Zhao et al. 2005). However, since lung 
epithelial cells express VEGFRs (Compernolle et al. 2002) this effect may also have 
been a direct inhibitory effect on epithelial proliferation or differentiation, and does not 
unequivocally support the notion that discrete vascular signals regulate epithelial growth 
and branching. Mesenchymal-derived VEGFs are known to be involved in the patterning 
of the embryonic lung vasculature as well (Greenberg et al. 2002), and the role of 
mesenchymal-derived angiogenic factors in pulmonary vascular development should not 
be overlooked despite the overwhelming suggestion in the literature that epithelial-
derived VEGF-A is the greatest source.  
 
1.7 Summary of important signals in lung development 
 
 
A proposed “organizer zone” exists during lung development at the epithelial-
mesenchymal interface of the most distal buds (Warburton et al. 2000, Figure 4, left 
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panel). Behind this organizer zone, the epithelium and surrounding mesenchyme 
differentiate and the matrix is stabilized, promoting a quiescent state in the cells. In the 
organizer zone the epithelial cells are not yet differentiated and are still undergoing 
proliferative, invasive branching of the surrounding mesenchyme.  Important signals 
include fibroblast growth factors (FGFs), most notably FGF10, sonic hedgehog (SHH), 
bone morphogenic proteins (BMPs), most notably BMP4, as well as proteases at the 
leading edges and clefts. In addition, matrix variations mediated by myofibroblasts are 
particularly important at the branch nodes/clefts. Figure 4 (right panel) illustrates the 3 
major peptide growth factor signaling pathways active at the epithelial-mesenchymal 
interface, namely FGF, BMP and SHH pathways. FGF10 signals to FGFR2b on 
epithelial cells and also binds HSPGs, resulting in activation of MAPK pathways and cell 
cycle progression, in addition to several other signaling activities. BMP4 produced by the 
epithelium feeds back negatively on FGF10 signaling first by autocrine mechanisms that 
involve sprouty-2 inhibition of FGFR-MAPK signaling, and second by paracrine 
mechanisms that result in activation of mesenchymal Smads which inhibit FGF10 
expression, acting as a negative feedback loop. SHH is expressed by the epithelium, 
and does not appear to be influenced by either FGF or BMP pathways, however SHH 
signaling in the mesenchyme via the receptor protein patched-1 (Ptc1) and the 
associated signaling protein smoothened (Smo) results in Gli-family transcription factor 
activation that inhibits FGF10 expression on the transcriptional level. 
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Figure 4: Important signaling molecules and pathways in lung development. Taken from 
Warburton et al. (2000): schematic illustrating the signaling events described in detail in 
the text.  
 
 
 
1.8 Fibroblast growth factors 
 
 
The fibroblast growth factor (FGF) family has critical roles in the development of all 
organs, as they affect cells derived from all three embryonic germ layers, mediating 
diverse cellular process including proliferation, migration, and differentiation. In order to 
appreciate how the role of these FGFs in lung development are mediated it is important 
to understand FGF-FGFR signaling. In Figure 5 (Hefti et al. 1997), a specific pathway for 
FGF-2 induced signaling is shown involving cardiac myocytes (Figure 5A) and a more 
general pathway diagram of multiple potential pathways activated by engagement of an 
FGFR by an FGF ligand (Figure 5B). As is illustrated in Figure 5A, FGFR signaling first 
involves the action of Grb2, leading to RasGTP-mediated activation of Raf then 
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MEK/ERK activation, culminating in ERK mediated transcription of target genes in the 
nucleus. Figure 1B highlights other potential FGF mediated signaling events. These 
involve action on cytosolic substrates including the cytoskeleton, the aforementioned 
ERK-mediated pathways, as well as the other MAPKs, JNK and p38 kinase (p38/RK) 
activated gene transcription.  
  
A B  
Figure 5: FGF signaling pathways. (taken from Hefti et al. 1997). A: FGF-2 signaling 
pathway leading to ERK-activated transcription of target genes; B: More generalized FGF 
signaling cascades, illustrating potential pathways activated upon FGF-FGFR 
engagement, a subset of which are likely activated depending on other signaling inputs 
and relative levels of involved proteins. 
 
 
 
Of the 24 or so members of the fibroblast growth factor family currently identified, FGFs-
1,2,7,9,10, and 18 are expressed in the developing lung, as well as all the fibroblast 
growth factor receptors (FGFRs)-1,2,3,4 (Hyatt and Shannon 2004).  FGFRs have 
known ligand specificity based on alternatively spliced mRNA forms of FGFR gene 
products (Ornitz et al. 1996). A general trend in the lung, and other organs with 
prominent endodermal-mesodermal interactions, the epithelium expresses 
predominantly “b isoforms”, while mesenchymal cells express “c isoforms”. Figure 6 
shows a table from Ornitz et al. (1996) depicting quantification of FGF-mediated MAPK 
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activation and proliferation and specific receptor-ligand activities in engineered cell lines. 
Importantly to this thesis, FGF7 (which binds the same receptor as FGF10) interacts 
almost exclusively with FGFR2b, which is a lung epithelial receptor. Also of interest are 
receptor binding properties of FGF2, which binds many receptor isoforms but has 
preference for “c isoforms”. These data suggest that FGF10/7 are epithelial-specific, 
while FGF2 is more of a “pan FGF”, but generally targets mesenchymal “c isoforms” with 
higher affinity. 
 
 
Figure 6: FGF-FGFR ligand-receptor specificities. Table taken from Ornitz et al. (1996) 
which shows relative signaling activities initiated by numerous FGF-FGFR interactions. 
The data reflect the relative level of mitogenic activity elicited by the indicated FGF in 
engineered cell lines which express the indicated FGFR isoform, with the mitogenic 
activity elicited by FGF1 (the universal FGF) being set at 100%. 
 
1.8.1 FGF10 
 
 
Among the FGFs present in the developing lung, FGF-10 and FGF-7 have been 
investigated most extensively (Hyatt and Shannon 2004). FGF-10 knockout mice 
completely lack lung development beyond the trachea (Min et al. 1998), while deficiency 
for the associated receptor FGFR2, results in a similar phenotype (Arman et al. 1999). 
Functionally, FGF-10 expression in the lung mesenchyme patterns the 
branching/budding epithelium (Bellusci et al. 1997a, also see Figure 7) and also has a 
role in lineage specification and induction of cytodifferentiation (Hyatt et al. 2004).  
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1.8.2 FGF7 
 
 
FGF-7 signals through FGFR-2, similarly to FGF-10, and this receptor ligand interaction 
has been implicated in lung branching morphogenesis (Post et al. 1996). Its function, 
however, seems to be redundant, based on the observation that FGF-7 -/- mice display 
no abnormal lung phenotype (Guo et al. 1996). FGF-7 was shown to be upregulated in 
the sub-epithelial mesenchyme of lungs with ectopic FGF9 expression, and was 
proposed to play a role in epithelial luminal dilation following stoppage of the FGF-10 
bud inducing signal (White et al. 2006). 
 
 
Figure 7: Illustration of how local gradients of FGF10 initiate bud elongation toward the 
FGF10 source. Taken from Warburton et al. (2000). The lower portion depicts FGF10 
interacting with both FGFR2 and cell surface heparin sulfate proteoglycans. Sprouty-2 
inhibits FGF10-FGFR2 signals potentially through extracellular inhibition of FGF10 or 
intracellular inhibition of FGFR2 intracellular RTK signaling.  
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1.8.3 FGF2  
 
 
FGF-2 (also known as bFGF) has been reported to influence lung epithelial 
differentiation (Matsui et al. 1999) and morphogenesis (Lebeche et al. 1999), however 
FGF-2 is perhaps best known as a potent angiogenic factor. In addition to the well-
elucidated role of FGF-2 in both in vitro (Babei et al. 1998) and in vivo (Hughes et al. 
2004) angiogenesis (development of blood vessels from pre-existing blood vessels), 
FGF-2 is also known to play a major role in vasculogenesis (vascular network assembly 
by differentiating endothelial precursor cells).  Exogenous FGF-2 induces in vitro 
hemangioblast differentiation of dissociated blastodisc cells that do not normally form 
blood islands (Flamme and Risau 1992), and mediates vascular development in the 
embryonic chick chorioallantoic membrane (Ribatti et al. 1995). Despite the extensively 
reported role of FGF-2 in vascular development, FGF-2 -/- mice display no abnormal 
lung phenotype (Ortega et al. 1998), indicating functional redundancy for FGF-2 in 
pulmonary vascular development in vivo. FGF2 expression patterns have been 
described in vivo during lung development (Powell et al. 1998) (Figure 8), where it is 
abundant in the mesenchyme at E18 in rats (canilicular stage), but importantly is 
detected in the saccular epithelial cells in addition to the distal mesenchyme during the 
saccular stage of lung development in which the terminal airways and alveolar vascular 
plexus develop. The observation that FGF2 is expressed in distal epithelium and 
mesenchyme during the saccular stage suggests a potential role for FGF2 in distal lung 
vascular development in vivo. 
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Figure 8: FGF2 expression in embryonic mouse lung. (Taken from Powell et al. 1998) A and 
B: FGF2 expression by IHC at E18 in rats (transition from pseudoglandular to canalicular 
stage). Panels C and D: FGF2 expression by IHC at the onset of saccular stage, E20 in rats. 
 
 
1.9 Vascular Endothelial Growth Factor A (VEGF-A) 
 
 
In embryonic development, VEGF-A is required for hemangioblast differentiation into 
endothelial cells and subsequent establishment of the cardiovascular circulation (Gilbert 
2005). VEGF-A is a known potent regulator of virtually all aspects of endothelial cell 
behavior; however VEGF-A and other members of the VEGF family signal to non-
endothelial cells in various organs, for example the recently appreciated role of VEGF-A 
as a neurotrophic factor (Lazarovici et al. 2006). This is especially true in the lung, where 
VEGF-A is truly pleiotropic, eliciting effects in endothelial, epithelial and mesenchymal 
cells via VEGFRs and other VEGF-binding receptors in these cell types. VEGF-A plays a 
particularly important role in adult lung biology, where in the adult lung it has been 
proposed to play a homeostatic role, being part of the “lung maintenance program” 
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(Voelkel et al. 2006). The fetal lung is also rich in this growth factor, and it signals to 
VEGFR proteins in lung epithelial (Compernolle et al. 2002), mesenchymal (Majka et al. 
2006) and endothelial cells (Akeson et al. 2003) during lung development. VEGF-A has 
been speculated to be an autocrine maturation factor for alveolar type II cells 
(Compernolle et al. 2002), however delivery of VEGF165 failed to induce proliferation of 
cultured rat fetal type II cells (Raoul et al. 2004), suggesting that VEGF-A may impact 
surfactant physiology in alveolar type II cells, but does not appear to directly influence 
epithelial proliferation or morphogenesis. In other studies, inhibition of VEGF receptor 2 
(Flk-1) resulted in decreases in arterial density and overall alveolarization (Jakkula et al. 
2000). In addition to the known effects of VEGF-A in the orchestration of endothelial and 
epithelial cell interactions during lung development and maturation (Del Moral et al. 
2006), pulmonary mesenchymal cells have been shown to express VEGFR1, which 
mediates VEGF-A regulated turnover of fetal pulmonary mesenchymal cell in vitro 
(Majka et al. 2006). The sources of VEGF-A in the developing lung are widespread, with 
reports that both epithelial- (Akeson et al. 2003) and mesenchymal-derived VEGF-A 
(Greenberg et al. 2002) regulate distal lung vascular development in a spatially and 
temporally controlled manner. An important possibility that cannot be excluded, but has 
not been explicitly demonstrated in the literature for embryonic lung endothelial cells, is 
autocrine endothelial expression of VEGF, which has been described in several other 
contexts (Kanda et al. 2004, Seghezzi et al. 1998). It is known that adult lung 
microvascular endothelial cells produce high levels of VEGF protein (Voelkel et al. 2006, 
Stevens et al. 2005), and that autocrine VEGF production in these cells is increased 
upon hypoxia which is mediated through the hypoxia inducible mitogenic protein (HIMP) 
(Yamaji-Kegan et al. 2006).  
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Figure 9: Vascular Endothelial Growth Factor (VEGF) intracellular signaling pathways. Of 
particular interest is the inclusion on intracellular signaling pathways of FGF2 along with 
VEGF. Taken from: http://www.pharmgkb.org/search/pathway/vegf/vegf.jsp#  
 
 
Once bound to VEGFR, VEGF induces receptor dimerization that results in activation of 
several downstream signaling events, including MAPK activation (Figure 9) which is 
associated with endothelial proliferation, and PI3-K/Akt activation which is associated 
with endothelial survival and NO production (Figure 9). Highlighting the diversity of 
signaling functions of VEGF in endothelial cells, VEGFR2 ligand engagement also 
induces phosphorylation of local focal adhesion kinases and paxillin which contribute to 
endothelial cell motility and actin dynamics (Voelkel et al. 2006). As described in the 
review by Voelkel, Vandivier and Tuder (2006), VEGF gene transcription is regulated in 
a complex manner by several different inputs, including among others hypoxia and the 
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Akt pathway, all of which are shown above in Figure 9. One of the major stimuli of VEGF 
production which is clearly absent in our system is hypoxia, since our cultures are 
carried out at 21 % oxygen. According to the current paradigm, these relatively 
“hyperoxic” culture conditions as compared to the oxygen tension equivalent fetal lung 
cells in vivo experience (3-5%) should downregulate VEGF production, however these 
normoxic conditions are not as severe as the very high oxygen content in some 
hyperoxia models (> 90%, Hosford et al. 2003) used to demonstrate down regulation of 
VEGF. The extremely high oxygen systems are geared at recapitulating high oxygen 
delivery to infants with respiratory distress which is believed to contribute to the 
development of bronchopulmonary dysplasia, according to the “vascular hypothesis” 
(Abman 2001). Normoxic culture conditions likely result in decreased hypoxia inducible 
factor mediated gene transcription in fetal pulmonary cells; however the deleterious 
effects of hyperoxia experienced at very high levels are likely not elicited at normal 
oxygen tension.  
 
1.10 Sonic hedgehog  
 
 
Sonic hedgehog is a key morphogen involved in regulation of epithelial-mesenchymal 
interactions during embryonic development in many organ systems, including the lung 
(Bellusci et al. 1997b). The absolute necessity of SHH for proper lung development was 
illustrated in SHH -/- mice, which display a severe lung phenotype, with epithelial, 
mesenchymal and endothelial defects. In the lung, the endoderm-derived epithelium 
expresses SHH which signals to mesenchymal cells expressing the SHH receptor 
protein, Patched-1 (Ptc1). SHH binding of Ptc1 causes conformational changes which 
reverse Ptc1 inhibition of Smoothened (Smo), allowing Smo to initiate an intercellular 
signal resulting in the expression of target genes (Figure 10). SHH is involved in 
modulation of mesenchymal phenotype, regulation of mesenchymal proliferation, and 
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potentially regulation of pulmonary vascular development (White et al. 2006), although 
this has not been explicitly demonstrated to date. SHH signaling in the pulmonary 
mesenchyme affects Gli-family transcription factor activity, which in turn alters 
expression of signaling proteins such as Wnt proteins.  FGF10 and BMP4 appear not to 
be targets of SHH signaling, which is surprising considering that these proteins are 
central to regulation of lung epithelial branching morphogenesis and proximal-distal 
cytodifferentiation, respectively (Bellusci et al. 1997b). In regards to modulation of 
mesenchymal phenotype, it is believed that the SHH derived from the distal epithelium 
promotes proliferation of the sub-epithelial mesenchyme, and perhaps a switch from 
FGF10 to FGF7 expression, which promotes epithelial luminal dilation after branching 
(White et al. 2006).  
 
  
Figure 10: Hedgehog signaling diagram, modulation of gene expression in Ptc+ cells via 
Gli family transcription factors. (taken from Stecca et al. 2002). HH influences target gene 
expression by altering the relative levels and activities of repressor and activator forms of 
Gli factors, which are converted via proteolytic processes.  
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It has been shown that SHH is essential for endothelial tube formation during embryonic 
vasculogenesis in mesenchyme adjacent to endodermal tissues in avian embryos 
(Figure 11), however the specification of the angioblasts in the mesenchyme was SHH-
independent. It is likely that SHH represents an epithelial-derived morphogen that 
positively regulates distal vasculogenesis.  In addition to apparent direct morphogenic 
effects on endothelial cells expressing the Ptc1 receptor, SHH is also a known indirect 
angiogenic factor, leading to increased expression of VEGF-A, VEGF-B and VEGF-C, as 
well as Angiopoietin-1,2 in the developing myocardium, functioning to stimulate coronary 
vascular development (Lavine et al. 2006). Cyclopamine (11-deoxojervine), a SHH 
inhibitor used in some of the experiments in this thesis, is a naturally-occurring chemical 
isolated from the corn lily Veratrum californicum, that is a teratogen and can lead to 
cyclopia (holoprosencephaly) if ingested by the mother during fetal gestation. 
Cyclopamine inhibits SHH signaling by influencing the balance between the active and 
inactive forms of the Smoothened protein (Chen et al. 2002). Cyclopamine is currently 
being investigated as a treatment agent in tumors that result from excessive SHH activity 
(Taipale et al. 2000). 
 
  
 
Figure 11: Sonic Hedgehog in embryonic vascular morphogenesis. Taken from Vokes et 
al. 2004. QH1 staining of endothelial cells reveals lack of vascular tube assembly in 
mesenchyme of endoderm-denuded 3 somite-stage mesenchymal explants (left panels), 
with a similar effect observed in dorsal aorta formation and surrounding vascular 
assembly in embryos treated with cyclopamine from the 2 - 8 somite stages. 
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1.11 Extracellular Matrix in lung development 
 
The lung, along with all other organs, is comprised of both cells and extracellular matrix 
(ECM). Interaction of cells with the ECM modulates developmental processes and 
contributes to physiological function and pathophysiology at the organ, cellular, and 
subcellular levels. ECM components in the gas-exchange region of the lung include both 
fibrous interstitium and cell-associated basement membranes (Dunsmore and Rannels 
1996). Connective tissue elements of the interstitium, primarily elastin and collagen type 
I fibers, in part determine respiratory function by contributions to tissue compliance and 
to resistance to inflation (Dunsmore and Rannels 1996). The basement membrane 
underlies cells of both the alveolar epithelium and the capillary endothelium, exerting 
effects on these cells through cell surface integrin receptor-mediated interactions. The 
ECM coordinates lung development in concert with growth factor signaling first by 
providing mechanospatial cues and secondly by direct intracellular signals elicited by 
adhesion receptors such as integrins that are known to synergize with growth factor 
receptor initiated cascades in a myriad of biological contexts (Assoian and Schwartz 
2001). A specific example of this in lung development comes from experiments in which 
ablation of lung branching morphogenesis and distal cytodifferentiation occurred in 
response to simply disrupting chondroitin sulfate proteoglycans (CSPGs) by chlorate 
treatment in the lung explant preparation (Shannon et al. 2003) and similar results with 
tenascin-C inhibition in hypoxic lung explant cultures (Gebb et al. 2005). The interstitial 
fibrous ECM, specifically the elastic fiber matrix, is essential to lung alveolar 
development and physiological function, however the focus of the studies on ECM in this 
thesis is on epithelial and endothelial basement membranes (laminin) and the 
provisional ECM protein, tenascin-C (TN-C).  
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1.11.1 Basement membranes 
 
 
The structure and composition of epithelial and endothelial basement membranes and 
the surrounding ECM governs the behavior of developing epithelia and endothelia, and 
directly impacts how peptide growth factor signals are transduced. Laminin is a general 
component of all basement membranes; however, specific laminin isoforms have more 
discrete effects on lung development. For example laminin-10/11 (laminin 5 alpha chain 
containing isoforms) are crucial epithelial basement membrane components that have 
been shown to be required for distal lung development. Conditional deletion of Lam5a in 
lung epithelium resulted in marked decreases in overall VEGF levels and alveolarization 
(Nguyen et al. 2005). ECM proteins produced by the sub-epithelial mesenchyme, such 
as tenascin-C (TN-C) are believed to function in concert with laminin and other BM 
proteins to coordinate lung morphogenesis. In addition, fibronectin is present in the BM 
of the developing lung (Dunsmore and Rannels 1996, De Langhe et al. 2005). TN-C and 
FN will be discussed in more detail in the next section.  
 
1.11.2 Tenascin-C and Fibronectin 
 
 
Tenascin-C (TN-C), the predominant tenascin isoform expressed in the lung (Matsumoto 
1994), is believed to play a key role in epithelial branching morphogenesis and distal 
alveolarization, as indicated by localization of TN-C in the leading edge of budding 
epithelial tips during branching morphogenesis (Gebb et al. 2005), in the ECM 
surrounding the developing distal vasculature (Ihida-Stansbury et al. 2004) and the tips 
of extending septa during alveolarization (Young et al. 1994). The TN-C knockout mouse 
has several, originally unappreciated, defects, including impaired corneal wound healing 
with sutures, abnormal behavior and brain chemistry, and decreased hematopoietic 
activity in the bone marrow (Mackie and Tucker 1999) and demonstrates an inability to 
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vascularize experimental cardiac allografts (Ballard et al. 2006). In terms of lung 
development, the TN-C knockout mouse has clear defects in epithelial branching, 
culminating in reduced numbers of larger terminal airspaces, although these mice do not 
display overt respiratory complications (Roth-Kleiner et al. 2004).  In vitro lung explant 
experiments with TN-C-/- embryonic lungs demonstrated that the epithelium grows 
normally, but branches poorly (Roth-Kleiner et al. 2004). TN-C gene expression is 
controlled in embryonic lung mesenchyme in part by the homeodomain transcription 
factor Prx1. Prx1-/- mice display a severe lung phenotype, with cyanosis and death 
shortly following birth due to respiratory distress. A key feature of the Prx1 knockout 
mouse is a lack of TN-C protein in the lung, as well as an avascular distal mesenchyme 
(Ihida-Stansbury et al. 2004). TN-C is known to be a multi-functional protein that alters 
the adhesive state and consequently confers unique morphological states in cells via 
alteration of focal adhesion kinase (FAK) and cytoskeletal (RhoA) associated signaling, 
thus altering responses to soluble factors and mechanical forces (Jones and Jones 
2000). TN-C is known to modulate cell adhesion to fibronectin (FN), limiting the 
contractile behavior, and enhancing the migratory response of fibroblasts cultured in 
fibrin-fibronectin matrices (Midwood and Schwarzbauer 2002, Midwood et al. 2004). FN 
is essential for cell adhesion, morphology, migration, proliferation, and differentiation in 
the lung (Roman 1997). Recent studies have identified FN as a target of developmental 
signaling pathways that guide branching morphogenesis (Sakai et al. 2003), with 
functional significance clearly illustrated for the deposition of FN in developing clefts of 
the branching lung epithelium (De Langhe et al. 2005). Similar to TN-C, FN also has 
defined roles in angiogenic processes.  
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Chapter 2: Methodologies 
 
 
2.1 Isolation of E17.5 Murine Fetal Pulmonary Cells 
  
 
Embryonic day 17.5 (E17.5) murine fetal pulmonary cells (FPC) were obtained from the 
lungs of timed-pregnant Swiss Webster mouse fetuses (Charles River Laboratories), 
according to an approved protocol (IACUC #s 30511-original protocol for in vitro culture, 
16150-current protocol for in vitro culture). This protocol has not varied over the period of 
the experiments performed for this thesis, and is described in the Materials and Methods 
of both manuscripts included as Appendix material (Mondrinos et al. 2006a, Mondrinos 
et al. 2007a). In addition, a step by step protocol is provided as Appendix material.  
 
2.2 Two-Dimensional Cultures 
 
2.2.1 Low Density Cultures 
 
Immunohistochemical analysis of FPC cultured in 2-D on either Matrigel- (early studies) 
or collagen type I-coated (most recent studies) chamber slides was performed to 
characterize epithelial, mesenchymal, and endothelial cells present within the FPC 
mixture. For these experiments, FPC were seeded at low densities (100K per well in 4-
well chamber slide) in order to have the cells sufficiently sparse to count individual nuclei 
reliably using image analysis software. Periodic quality control experiments have 
revealed that the distribution of cells varies with different preparations (see section on 
Heterogeneity in the system in Chapter 7), with the reality being that there is a range of 
~30-50% epithelial cells and ~10-20% endothelial cells, and the balance being mixed 
mesenchymal cells.  
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2.2.2 High Density Cultures 
 
 
In select experiments, FPC were plated out at a high density (1 million FPC per well in 4 
well chamber slides) and cultured overnight. This resulted in the formation of 
overconfluent multilayer assemblies in which cells growing on top are attached to the 
cells and secreted matrix below them, not the tissue culture plastic. The phenomenon of 
altered morphology and cytoskeletal configuration of cells cultured on top of “feeder 
cells” has been described in the literature, and is attributed to the difference in stiffness 
(rigid plastic vs. compliant cells/matrix) (Discher et al. 2005). This configuration was 
adopted to assess “input material” in overnight culture, due to the enhanced structural 
organization, and consequently differentiation, compared to low density 2-D cultures, 
which promote cell spreading.  The disadvantage of this culture setup is that the high 
density “packing” of cell nuclei precludes counting total cell numbers. Data collected for 
FGFR1/FGFR2 staining, VEGFR1/VEGFR2 staining and also SHH and Ptc1 staining 
shown later utilized this culture configuration. 
 
2.3 Three-Dimensional Collagen Gel Cultures 
 
The protocol for generating 3-D collagen gel constructs is described in Mondrinos et al. 
(2007a), and a step by step protocol is provided as Appendix material. This protocol is 
described briefly here, but the following sections focus on providing details of how the 
various gain- and loss-of-function analysis experiments were performed for VEGF-A, 
SHH and TN-C. Freshly isolated E17.5 FPC were centrifuged and resuspended in a 1.2 
mg/ml liquid collagen solution (BD Biosciences, pH adjusted to 7.2-7.4), at a density of 
2.5 – 5.0 million FPC/ml.  0.9 ml of cell/collagen mixture per well was cast in 24 well 
plates and transferred to the incubator. Following polymerization of the gel, 2 ml of an 
80:20 mixture of DMEM/F12 medium (Cambrex) containing 10% fetal bovine serum 
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(Hyclone), L-glutamine, and penicillin-streptomycin antibiotics was overlaid and the 
constructs were incubated overnight. Subsequently, the constructs were maintained in 2 
ml serum-free basal DMEM/F12 medium supplemented with 1% insulin-transferrin-
selenium (BD Biosciences) and heparin (Sigma, 10 units/ml) (1% ITS); 10% FBS, or 
experimental media as described in the sections below.  
 
2.3.1 Fibroblast Growth Factor experiments 
 
 
For the experiments of Specific Aim # 1, in which the effects of exogenously 
supplemented FGFs on lung tissue construct morphogenesis were assessed, 1% ITS 
basal medium was supplemented with FGF7 (Sigma, 10 ng/ml), FGF10 (Sigma, 25 
ng/ml) or FGF2 (Sigma, 12.5 ng/ml) alone or in combination as follows: FGF10; FGF7; 
FGF2; FGF10/7; FGF10/7/2.  
 
2.3.2 Vascular Endothelial Growth Factor experiments 
 
 
For VEGF-A loss-of-function experiments, a soluble VEGFR1-Fc chain chimeric protein 
(sVEGFR, R & D Systems) was added to the gel and the medium at doses ranging from 
300 ng/ml – 2 µg/ml. The sVEGFR1 approach was chosen in order to specifically 
sequester VEGF-A protein in the extracellular space, without manipulating intracellular 
signaling activities in cells (see Chapter 2 for details on experimental setup). The reason 
for this was to ensure that VEGF-A sequestration, i.e. knockdown of secreted VEGF-A, 
would be contributing to inhibition of endothelial morphogenesis, rather than apoptosis 
induction in endothelial cells, as has been shown to occur in response to treatment with 
VEGFR receptor tyrosine kinase inhibitors, such as SU-5416 (Kashara et al. 2000). For 
VEGF-A gain-of-function experiments, recombinant human VEGF-A (Sigma), was added 
to the cell culture medium at doses of 10 ng/ml or 50 ng/ml to the 1% ITS basal medium, 
in the presence or absence of the various FGFs. 
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2.3.3 Sonic Hedgehog experiments 
 
 
SHH gain- and loss-of-function experiments utilized SHH peptides and cyclopamine, 
both of which are highly diffusible and are typically used as additives to the culture 
media in embryonic lung (White et al. 2006) and heart (Lavine et al. 2006) explants. 
Sonic hedgehog protein (N-terminal peptide, R & D Systems) was added at 500 ng/ml. 
In SHH inhibition experiments, cyclopamine was added to a final concentration of 5 µM. 
Cyclopamine (Sigma) stock solution was prepared at 10 mM in dimethyl sulfoxide 
(DMSO).   
 
 
2.3.4 Tenascin-C experiments 
 
 
Experiments utilizing exogenous TN-C protein and TN-C neutralizing antibodies were 
held to 96 hours, due to the cost of including the reagent in the collagen-cell mixture at 
the desired concentration, as well as the cell culture medium, in the 10-20 µg/ml range. 
Inclusion of the protein or antibodies in the gel at the desired concentration eliminates 
the need for diffusion to occur in order to attain desired local concentrations at the cell 
surface. With the reagent in the medium replenishing the gel and replaced at 48 hours, it 
is assumed that the concentration in the gel is relatively constant throughout the 96 hour 
duration of the experiments. For TN-C gain-of-function experiments, exogenous TN-C 
protein (Chemicon) was added to the gel and the medium at 10 µg/ml, with the medium 
replaced at 48 hours. For TN-C loss-of-function experiments, rabbit polyclonal antibodies 
against TN-C (Chemicon) were added to both the gel and the medium at 20 µg /ml, with 
the medium again being replenished at 48 hours containing 20 µg/ml anti-TN-C IgG.  
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2.4 Paraffin Processing and Routine Histology 
 
In select experiments, some samples from all types of 3-D assemblies (Matrigel, polymer 
scaffolds, in vitro & in vivo collagen gel constructs) were processed for routine histology 
(H&E staining) and immunoperoxidase staining. Briefly, formalin fixed samples were 
dehydrated through a series of graded alcohols, cleared with xylene, and embedded with 
paraffin wax according to standard protocol. Ten micrometer sections were cut using a 
rotary microtome (Leitz 1512), deparaffinized, rehydrated, and stained with hematoxylin 
and eosin. 
 
2.5 Immunohistochemistry 
 
The presence of epithelial cells was assessed by immunostaining for cytokeratin (pan 
cytokeratin, rabbit(Rb) polyclonal, DAKO) and prosurfactant protein C (Rb polyclonal, 
Chemicon), respectively. Cytokeratins are a ubiquitous epithelial intermediate filament, 
and proSpC is a differentiation marker of distal, AE2-lineage cells. Endothelial cells were 
detected primarily by isolectinB4 staining (see section 2.6 on isolectinB4), however 
immunostaining for the endothelial phenotype markers PECAM-1/CD-31 (rat 
monoclonal, Abcam), von Willebrand factor (Rb polyclonal, DAKO), and Vascular 
Endothelial Growth Factor Receptors 1 and 2 (Rb polyclonals, Neomarkers). 
Immunostaining for vascular endothelial growth factor A was also performed to identify 
cellular sources of VEGF-A (Rb polyclonal, Neomarkers). Vimentin was used as a pan-
mesenchymal marker, while tropoelastin was utilized as a marker for identifying a subset 
of lung mesenchymal cells (Bruce and Honaker 1998, Nakamura et al. 2000) and for 
evaluating how exogenous FGFs might affect mesenchymal proliferation. Tropoelastin-
positive cells, with fibroblastic morphology were present in the interstitial spaces of all 
constructs (Mondrinos et al. 2007a). Cellular expression of SHH (Rb polyclonal, Santa 
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Cruz) and the associated receptor, Ptc1 (Rb polyclonal, 1:50) were assessed by 
immunostaining. The distribution of matrix proteins laminin (pan laminin, Rb polyclonal, 
Chemicon), TN-C (Rb polyclonal, Chemicon) and fibronectin (Rb polyclonal, Chemicon). 
For double staining experiments with laminin and TN-C or fibronectin, chicken anti-
laminin polyclonal antibodies (Abcam) were used in combination with Rb polyclonals 
against TN-C or fibronectin. The general morphologies of cells (clustered cells = 
cytokeratin+ epithelium, diffuse single cells = mixture of mesenchymal/endothelial cells) 
taken together with isolectinB4 allowed for discerning epithelial vs. mesenchymal 
phenotypes in later experiments labeling for VEGFRs and FGFRs.   
 
2.5.1 Immunoperoxidase and Immunofluorescence section staining 
 
 
For visualization with peroxidase-labeled secondary antibodies, sections were treated for 
5 minutes with 0.3% H2O2 in methanol to block endogenous peroxidase activity. In order 
to block non-specific binding sites, a blocking step with 3% BSA in TBS pH 7.4 for 30 
minutes was used, and all steps were carried out in TBS containing 1% BSA. Primary 
antibodies were generally used at dilutions of 1:100 – 1:250 for 90-120 min incubations 
at room temperature, and secondary antibodies at dilutions of 1:1000 for 30 min 
incubations at room temperature. 
 
2.5.2 Whole Mount Immunohistochemistry 
 
Morphologic and phenotypic characterization of our in vitro constructs was carried out 
utilizing a whole mount indirect fluorescent immunohistochemistry (IHC) protocol similar 
to that used for whole mount staining of embryos and explants (Sillitoe and Hawkes 
2002, Snow et al. 2005). This protocol is described in detail in Mondrinos et al. (2007a), 
and a detailed, step by step protocol is included as Appendix material.  
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2.6 IsolectinB4 as a Rodent Endothelial Marker 
 
 
The endothelial specificity of isoB4 has been reported previously (Laitinen 1996, Hyink 
et al. 1996, Akeson et al. 2005) and was also confirmed in our hands by co-
immunofluorescence staining for VEGFR1, VEGFR2, and CD-31 (Mondrinos et al. 
2007a). IsolectinB4 staining is far more uniform than CD-31 immunostaining, and was 
therefore utilized for 3-D visualization of EC tubular morphogenesis. The use of mature 
endothelial markers for embryonic endothelial cells is inherently problematic, as these 
cells are actively differentiating.  
 
2.7 Quantitative Image Analysis and Statistical Analysis 
 
 
2.7.1 AFU area analysis and subjective bud counts 
 
Quantitative analysis of phase contrast images of alveolar forming units (AFUs) taken at 
7 days was carried out using NIH ImageJ. Images were all taken at 100x magnification.  
For each sample/condition/experiment a minimum of 10 images containing ~25 
individual AFUs were analyzed. Individual AFUs were manually outlined using the region 
of interest (ROI) selection tool. Once selected, the area of individual AFUs (pixels) was 
measured.  Normalized areas were calculated for each independent experiment, setting 
1% ITS equal to 1. Normalized mean areas for each independent experiment were then 
averaged to yield a cumulative value. The data are represented as fold increase over 1% 
ITS. Rudimentary bud counts for individual AFUs were performed manually in parallel 
with area measurements and the results were normalized to 1% ITS in a similar fashion. 
As an example of this method, Figure 12 below illustrates 2 outlined AFUs in a single 
phase contrast image, with the subjectively assessed “buds” indicated by arrows. 
Statistical analysis of the area measurements and bud counts were carried out by one-
way ANOVA with the Tukey post-test (T-test) for individual comparisons between area 
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values for the various media supplementation conditions, with p < 0.05 being regarded 
as statistically significant, and further significance assigned for p < 0.01. 
 
 
Figure 12: Enhanced illustration of how the region of interest (ROI) tool in ImageJ is used 
to outline the border of developing alveolar forming units for area measurements. AFUs 
are outlined and the area measured one at a time, but here 2 structures are outlined for 
illustrative purposes. The subjective bud counting process is diagrammed for the upper 
AFU, where 11 distinct buds are counted.  
 
 
 
2.7.2 Endothelial Index of Elongation/Interconnectivity 
 
Quantitative assessment of vascular network formation was performed by image 
analysis of isolectinB4 whole mount staining visualized in 3-D by laser scanning confocal 
microscopy. A morphogenetic index, termed the index of elongation and interconnectivity 
was determined by measuring the fraction of total area of isoB4 staining contributed by 
interconnected/elongated EC area vs. single EC: 
 
Index of Elongation/Interconnection = pixels of interconnected EC/total EC pixels 
 
 
Quantification of isoB4 staining in laser scanning confocal micrographs was carried out 
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using NIH ImageJ. For each experimental condition we analyzed at least 20 randomly 
acquired 200x fields at comparable z-positions taken from at least 2 whole mount 
constructs. Individual images were binarized, and total area of isoB4 stained pixels per 
200x microscopic field was calculated. Statistical analysis of the area measurements 
was carried out by one-way ANOVA with the Tukey post-test (T-test) for individual 
comparisons between area values for the various media supplementation conditions. P 
values were calculated by Student’s t-test with p < 0.05 being regarded as statistically 
significant, and further significance assigned for p < 0.01. 
 
 
Figure 13: Illustration of how the endothelial Index of Elongation/Interconnection metric is 
calculated. Single channel isolectinB4 confocal images were converted to 8-bit grayscale 
and then converted to binary images by using the Image > Adjust > Threshold function in 
ImageJ. The same threshold intensity was applied to the same image in which single 
endothelial cells (EC) were manually removed (bottom panels). The ratio of pixels is then 
calculated to determine the fraction of pixels contributed by elongated/interconnected EC, 
with a value of 1 indicating a complete network with no single EC. For the example above 
in Figure 13, the Index of Elongation/Interconnection is: (13074 pixels of 
elongated/interconnected EC) / (16830 total pixels) = 0.78 
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2.7.3 Cell counting in micrographs 
 
Due to the diffuse nature of stained mesenchymal cells, these cells could be counted 
using ImageJ based on phenotype stain as illustrated in Figure 14 (individual cells are 
recognized as separate objects). Conversely, epithelial cells which form aggregated 
structures could only be counted based on parallel nuclear staining. The numbers of 
epithelial cells in sections taken at the plane of greatest cross-sectional area were 
counted manually on a per AFU basis. In both cases, the number of cells for 1% ITS was 
set equal to 1 and all other conditions normalized and reported as fold increase. 
Statistical analysis entailed one-way ANOVA with the Tukey post-test (T-test) for 
individual comparisons between area values for the various media supplementation 
conditions, with p < 0.05 being regarded as statistically significant, and further 
significance assigned for p < 0.01. 
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Figure 14: Counting labeled mesenchymal cells in confocal images. Top panels: optical 
sections of Ptc1 whole mount staining, ITS (left panel) and FGF2 (right panel). Bottom 
panels: segmentation and pixel cluster size discrimination used to identify and count Ptc1 
positive cells in ImageJ. For the example shown, the computer generated counts were 14 
and 78. 
 
 
2.8 VEGF-A ELISA Assay 
 
 
Total VEGF-A protein levels were quantified across conditions in several series of 
experiments using a commercially available ELISA kit (Biosource) to measure the 
concentration of VEGF-A secreted into the culture medium. Media samples from the 
various culture conditions tested were aliquoted and stored at -80 C until assay. It was 
determined empirically that 1:20 and 1:100 dilutions should be prepared for each sample 
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in order to ensure that samples fall within the linear range of the assay (< 500 pg/ml). 
The concentration for 1% ITS was set equal to 1, and the concentrations for the various 
experimental conditions are reported as fold increase. Statistical analysis of the area 
measurements was carried out by one-way ANOVA with the Tukey post-test (T-test) for 
individual comparisons between area values for the various media supplementation 
conditions. P < 0.05 was regarded as statistically significant, with further significance 
assigned for p < 0.01 
 
 
2.9 Viability Staining 
 
 
Cell viability was assessed at 7 days in select experiments by using the LiveDead™ kit 
(Invitrogen). Briefly, following removal of cell culture medium, 1 ml of 2 µM ethidium 
homodimer and 4 µM calcein-AM in 1X PBS was added to the constructs, which were 
then incubated for 30-45 minutes at room temperature on an orbital shaker.  Samples 
were then washed with 1X PBS (3 x 5 minutes) and immediately imaged on a 
fluorescent microscope (Leica). Imaging was delicate, as the unfixed samples were 
fragile. Photobleaching of the calcein-AM during focusing in the 3-D gels was also 
problematic. Nevertheless, differences in the viability of cells in constructs cultured with 
the various media were clearly discernible. 
 
2.10 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
 
 
Collagen gel constructs were digested and RNA extracted with TriReagent™ (Sigma) 
according to our previously published protocols (Mondrinos et al., 2007a). RT-PCR was 
performed using a commercially available kit (Promega) following the manufacturer’s 
instructions. Primers were obtained from Quiagen based on sequences from the 
Clontech AtlasTM (Mouse 1.2 Array II, Cat. #7857-1, BD Biosciences) and RT-PCR 
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carried out as previously published (Mondrinos et al. 2006a, 2007a). Total RNA isolated 
from E17.5 fetal pulmonary tissue was used as a positive control. Negative controls 
included no reverse transcription samples, as well as reactions without the addition of 
the cDNA template.  
 
 
2.11 In Vivo Studies 
 
 
The experimental methods for the Matrigel plug experiments are provided in the 
manuscript attached as Appendix material (Mondrinos et al. 2007b, under revision). In 
brief, FPC isolated according to the standard protocol (Mondrinos et al. 2006a, 
Mondrinos et al. 2007a) were admixed to normal (not growth factor-reduced) liquid 
Matrigel (BD Biosciences) at a density of 5 million FPC per ml, at a volume ratio of 1 part 
cell suspension to 9 parts Matrigel. In order to generate the plugs, 600 µl of FPC-
containing Matrigel suspension was injected on flank of adult syngeneic, and in select 
cases allogeneic, mice. In the case of addition of FGF2-soaked sponges, following 10 
minutes for Matrigel solidification, the plug was carefully incised and polyvinyl sponges 
loaded with 100 ng of recombinant human FGF2 were inserted in the plug center.  
 
For the renal capsule model experiments, collagen type I gels were used rather than 
Matrigel, and constructs were generated in vitro prior to in vivo engraftment. FPC were 
isolated per protocol and suspended in 1.2 mg/ml collagen solution as for most in vitro 
experiments. Due to the relatively small size required to comfortably fit beneath the renal 
capsule, constructs were cast in a 48 well plate at an initial volumes of 300 or 400 µl. 
The reason for using 2 initial volumes was varying degree of gel contraction in each 
experiment, thus allowing for use of constructs with a consistent final size for the 
implantations. Importantly, to facilitate gel contraction, gels were first detached following 
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the first night of culture, and cultured in small Petri dishes on an orbital shaker (Belly 
Dancer, Stovall) to facilitate gel contraction. In addition, serum was kept in the medium 
at a concentration of 5% in addition to FGF10/7/2 at the previously described 
concentrations. The combination of gel detachment, agitated culture, and culture with 
serum-containing medium facilitated optimal gel contraction and consequently size and 
mechanical properties (as subjectively assessed by the surgeon performing the 
implantation). An important side note is that all of these factors were not implemented in 
the normal in vitro culture system, and actually impact negatively on histiotypic 
morphogenesis. These approaches were however required to achieve the practical end 
of having a construct that is capable of being handled with forceps and physically 
manipulated without deforming. Renal capsule implants were performed by Dr. Christine 
Finck. In select experiments looking at effects of FGF10/7/2 in vivo, 2 polyvinyl sponges 
loaded with 100 ng of each FGF were positioned on opposite sides of collagen gel 
constructs. The significantly smaller size relative to the Matrigel plug implants (~ 50 vs. 
500-600 µl) did not allow for placing sponges in the center of the constructs.  
 
In select experiments FPC were tracked by labeling with CMTPX CellTracker™ dye 
(Invitrogen) according to manufacturers protocol. Briefly, cells were incubated for 30 
minutes in 25 µM CMTPX in serum-free medium, then washed several changes prior to 
suspending in collagen gel as described earlier. Upon completion of the experiments, 
constructs were harvested and fixed in 4% paraformaldehyde overnight, then 
refridgerated in PBS until histological and immunohistochemical analysis as described 
earlier. Similar markers to the aforementioned in vitro staining experiments were used: 
proSpC, VEGF-A, laminin, TN-C, and FN. 
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Chapter 3: Collagen Gel-based 3-D Constructs: A Potential Model for Single 
Molecule Studies and Pathway Analysis in Engineered Lung Tissues 
 
3.0 Preliminary Studies - 3-D Matrigel and Synthetic Polymer Scaffold Experiments 
 
The preliminary studies on isolation, culture and characterization of FPC in 2-D, as well 
as 3-D culture experiments in Matrigel and synthetic polymer scaffolds are described in 
detail in Mondrinos et al.  (2006a). This section highlights the salient features of the 3-D 
Matrigel culture studies, which serve as the basis for subsequent experiments in 
collagen gels. Culture in synthetic polymer scaffolds did not support lung morphogenesis 
or epithelial differentiation, a topic which is discussed in the closing chapter. In the 
absence of specific growth factor supplementation (see below), FPC cultured inside 3-D 
Matrigel formed ring-like structures which resemble alveoli in vivo. We termed these 
nascent epithelial structures “alveolar forming units” (AFUs). These structures are seen 
as early as 24 hours post-isolation and increase in size for up to 4 weeks in culture in 
either serum free (1% ITS) or 10% FBS medium (Mondrinos et al. 2006a).  Transmission 
electron microscopy analysis revealed gap junctional complexes, microvilli, and lamellar 
bodies & tubular myelin indicative of differentiated distal epithelial or AE2-lineage cells 
(Mondrinos et al.  2006a).  These features are necessary to demonstrate that epithelial 
differentiation is maintained, and was found to correlate with staining of prosurfactant 
protein C in cuboidal cells in and around AFU lumens (Mondrinos et al.  2006a). In later 
studies with collagen gels, ultrastructural assessment of cell differentiation was not 
performed, and staining of proSpC in cuboidal cells lining AFUs was considered an 
adequate assessment of maintaining distal epithelial differentiation. H & E staining of 
Matrigel constructs following 1 week of culture with FGF10/7/2 revealed branching 
structures complete with lumens which resembled ductal structures present in saccular 
stage fetal lung (Mondrinos et al.  2006a). Importantly, we observed enhanced budding 
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behavior in favor of cyst expansion in the media containing the FGFs.   
 
3.1 Switch to the Collagen Gel-based System 
 
 
The collagen type I gel system was considered desirable because it was not tumor-
derived, and also was a homogeneous matrix which: 1 – allowed for more accurate 
interpretation of single factor effects, 2 – allowed for analysis of ECM production by the 
cells, since only collagen type I is present initially, and 3 – allows for development of a 
“defined ECM gel” by adding in additional matrix proteins, as was performed in select 
experiments with tenascin-C (TN-C). Based on the preliminary observations that 
FGF10/7/2 promoted epithelial branching morphogenesis in Matrigel, it was 
hypothesized that FGF10/7/2 would be able to promote a similar morphogenic response 
in collagen type I gel constructs. The remainder of the in vitro work described in this 
thesis focuses on using the homogeneous type I collagen gel as a 3-D matrix for 
characterizing the effects of exogenously added morphogens such as FGFs and SHH, 
on the processes of epithelial and endothelial morphogenesis, with particular emphasis 
on in vitro vascular development. The collagen gel culture system used in all subsequent 
experiments is summarized briefly below.  
An important feature of these collagen gel constructs is that they have a polarity. During 
the gelation process, the larger/denser epithelial aggregates tend to settle to the bottom 
of the gels (Figure 15, Figure 16). This turns out to be serendipitously convenient, since 
the majority of “vascularized AFUs” arise in the lower 0-500 microns of the gel, a 
distance which compresses slightly with cover-slipping during whole mounting, thus 
these structures are easily imaged in their entire thickness by whole mount IHC and 
confocal microscopy. Importantly, the gels are not detached from the well during the 
culture period, which helps to limit gel contraction, and presumably stiffening that comes 
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along with this contraction. It was observed in early experiments that AFUs branched 
poorly in detached gels, which were allowed to contract, relative to attached gels which 
retain more volume and “feel softer” at the end of the experiment when handling. 
Chapter 8 discusses the topic of detached gel cultures aimed at facilitating gel 
contracting. The majority of experiments conducted were for 7 days, with select 
experiments for 14 days and also for shorter time periods, especially in loss of function 
experiments involving costly reagents, which usually were stopped at 96 hours. Some 
RT-PCR experiments were performed on total RNA extracts from collagen gel 
constructs, as described in Chapter 2 and Mondrinos et al. (2007), however the majority 
of the analysis in this and the following chapters is based on the whole mount 
immunohistochemistry (wmIHC) protocol developed and 3D confocal microscopy 
(Chapter 2 and Mondrinos et al. 2007a for details).  
 
 
Figure 15: Phase contrast image depicting freshly isolated FPC suspended in a collagen 
gel. The focal plane is near the bottom of the gel, just above the plastic dish. Several large 
epithelial aggregates (arrows) are seen, which will give rise to the “AFUs”. The epithelial 
cells are very “sticky” and tend to re-aggregate during dissociation and subsequent 
processing steps prior to making the gels. In addition to the aggregates, there are 
populations of monodispersed cells, which appear to be the mesenchymal and endothelial 
cells based on the staining analysis at 24 hours post gel formation. 
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Figure 16: Diagram depicting the initial distribution of cells within collagen type I gel 
constructs. Larger epithelial clusters which give rise to AFUs generally settle at the 
bottom of the gel, and in this region most vascular development occurs. 
41 
3.2 Statement of Specific Aims  
 
 
The main Specific Aims of this thesis, which involve the implementation of the collagen 
gel-based culture system described above, and the associated hypothesis for each aim 
are stated below.  In this and the following chapters the data is presented and discussed 
in a continuous narrative based on the overall structure of the thesis, not necessarily 
according to the specific aims as stated below.  
 
Specific Aim 1 (Chapter 3): Characterize the effects of exogenous FGFs, FGF10, 
FGF7, and FGF2, on epithelial proliferation and budding/sacculation, mesenchymal 
proliferation, and vascular development in collagen gel-based constructs in vitro. 
 
Hypothesis:  The development of a cocktail of specific FGFs which preferentially signal 
to either epithelial cells (FGF10/7) or mesenchymal/endothelial cells (FGF2), based on 
FGFR splice variant ligand specificities, will allow for “engineering” of 
proliferative/morphogenic responses of diverse cell populations in the organotypic FPC 
mixture. 
 
Specific Aim 2a: Characterize changes in localization patterns and measures of total 
VEGF-A protein levels in response to FGF supplementation conditions and correlate to 
endothelial network formation; and confirm the functional significance of VEGF-A in 
vascular development observed in response to FGF supplementation via loss-of-function 
studies. 
 
Hypothesis: Based on the known role of VEGF-A as a pleiotropic endothelial growth 
factor, the diversity of cellular sources of VEGF-A in the lung, and the known quantitative 
relationship of VEGF-A levels and levels of vascular development in vivo during lung 
organogenesis (Akeson et al. 2003); it is hypothesized that there will be a similar 
quantitative relationship between VEGF-A protein levels and in vitro vascular 
development in the FGF-treated collagen gel constructs.  
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Specific Aim 2b: Characterize expression of SHH signaling pathway components, SHH 
and Ptc1, in isolated FPC, and in 3-D collagen gel constructs, and determine the 
functional significance of SHH signaling in vascular development observed in response 
to FGF supplementation, and potentially the absence of exogenous FGF, via gain and 
loss-of-function experiments. 
 
Hypothesis: Since SHH is essential for lung development in vivo, and is a key 
epithelial-derived morphogen, it was hypothesized that SHH is a key mediator of in vitro 
vascular development in combination with VEGF-A, and specifically may be involved in 
preferential lumen formation of endothelial tubules in contact with epithelium. 
 
Specific Aim 2c: Characterize the formation of epithelial and endothelial basement 
membranes, and the localization pattern of TN-C in response to FGF supplementation 
conditions, and assess the functional significance of TN-C via gain and loss-of-function 
studies. By double staining of TN-C and LM determine the distribution of TN-C in and 
around epithelial and endothelial basement membranes and correlate to local 
morphogenic state. 
 
Hypothesis: Based on the known in vivo role of TN-C in epithelial and endothelial 
morphogenesis in the lung and other organs, it was hypothesized that TN-C deposition 
in the ECM, and in a broader sense, enhanced turnover/remodeling of epithelial and 
endothelial basement membranes would correlate positively with observed 
morphogenesis. 
 
Specific Aim 3 (Chapter 8): Determine if in vitro generated fetal lung tissue constructs 
are capable of maintaining epithelial differentiation, and whether graft-derived vascular 
structures contribute to in vivo vascularization, upon implantation in the renal capsule of 
syngeneic mice. 
 
Hypothesis: Based on establishment of microenvironment and tissue morphology in 
vitro, epithelial cells will maintain differentiation upon in vivo implantation and vascular 
structures present within the constructs at the time of implantation will anastomose with 
host circulation. 
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3.3 Effects of FGFs on E17.5 FPC in 3-D cultures in vitro 
 
 
In this section, the results presented in our AJP paper (Mondrinos et al., 2007a)  are 
discussed in condensed form, with the purpose of highlighting key observations that are 
the basis of the mechanistic studies presented in Chapter 4.  
 
3.3.0 Effect of FGF Supplementation on Construct Viability and Gene Expression 
 
 
Constructs cultured in FGF10/7/2 for 7 days exhibited high viability in the budding 
epithelial structures containing  only sparse individual dead cells (Figure 17B, 17C),. 
Conversely, the large spherical aggregates found in 1% ITS alone contained significant 
numbers of dead cells (Figure 17A). RT-PCR analysis of total RNA isolated from 
constructs cultured with FGF10/7/2 demonstrated expression of distal epithelial marker 
genes SpC and SpB. The mesenchymal-derived morphogen FGF10 and vascular 
endothelial growth factor A (VEGF) were detected in all constructs irrespective of the 
media and culture time, albeit at different levels relative to GAPDH (Figure 17D). 
Expression of the epithelial differentiation marker genes, SpC and SpB, across 
conditions suggest that baseline epithelial cytodifferentiation is retained in 3-D 
organotypic cultures and may be enhanced, but is not induced by exogenous FGF 
supplementation. Since low levels of proSpC protein expression are observed in cystic 
AFUs in 1% ITS cultures, it can not be concluded that exogenous FGF10/7/2 positively 
regulates SpC gene expression. Enhanced proSpC immunoreactivity observed in 
FGF10, FGF10/7 and FGF10/7/2 cultures may reflect increased proliferation of SpC-
expressing cells present in the input material. Without mRNA level data on a per 
epithelial cell basis conclusions on the impact of the FGFs on distal cytodifferentiation 
can only be inferred indirectly. 
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Figure 17: Viability staining and gene expression analysis of collagen gel constructs. 
Panel A: 1% ITS, 7 days, 100x, note the large aggregates of dead cells (red) consistent in 
morphology with cystic AFUs present in 1% ITS cultures demonstrated in earlier figures 
(arrows); Panel B: FGF10/7/2, 7 days, 100x, note the presence of large budding structures 
comprised of nearly all viable cells (green, arrows); Panel C: FGF10/7/2, 7 days, 400x, at 
higher magnification, note the excellent viability of the cells comprising epithelial buds 
(arrow) and endothelial tubules (arrowhead). Epithelial and endothelial identity in these 
images is inferred by morphology correlated with phenotypic staining in earlier Figures; 
Panel D: RT-PCR analysis for lung epithelial differentiation markers SpC and SpB, 
mesenchymal derived morphogen FGF10 and VEGF-A (VEGF), GAPDH was utilized as a 
loading control, 10% FBS = 10% fetal bovine serum, SF-ITS = 1% ITS, SF-FGFs = 
FGF10/7/2.  
 
 
 
3.3.1 Effect of FGF Supplementation on Epithelial Morphogenesis 
 
 
The initial assessments of epithelial morphogenic responses to FGF10, FGF7 and FGF2 
entailed phase contrast microscopy and quantification of a) AFU area, as a measure of 
epithelial growth, and b) rudimentary bud counts as a measure of epithelial 
morphogenesis as described in Chapter 2. Of all the single fibroblast growth factor 
additions to the medium, only addition of FGF10 resulted in a statistically significant 
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increase in AFU area and elicited a greater than 2 fold increase in rudimentary bud 
counts relative to FGF7 and FGF2 only. Co-supplementation of FGF10/7 and FGF10/7/2 
did not result in statistically significant increases in AFU area or numbers of buds/AFU 
relative to FGF10 only, however AFUs appeared more dilated. Supplementation with 
FGF10 alone induced a histiotypic budding architecture of the epithelial cells, which 
correlated with more uniform, intense proSpC staining in the cells lining these structures 
(Mondrinos et al.  2007a). This increased localization of proSpC in AFUs was even more 
pronounced in cultures supplemented with either FGF10/7 or FGF10/7/2.  
 
3.3.2 Effect of FGF Supplementation on Endothelial Morphogenesis 
 
 
3-D z-projections of isolectinB4 stained constructs revealed relatively uniform distribution 
of single EC within the first 24 hours post-seeding. This is important because it implies 
that in the conditions in which vascular plexus formation occurs, endothelial cells are 
coalescing, which involves 2 major cellular processes: migration and establishment of 
intercellular contacts. This fundamental observation of initially having dispersed 
endothelial cells, which migrate and aggregate to form multicellular assemblies was 
essential to interpreting the gain and loss of function studies for VEGF-A, TN-C and SHH 
in Chapter 4. Following 7 days of culture, all samples, with the exception of 10% FBS 
and 1% ITS, consistently contained elongated and interconnected ECs (Mondrinos et al. 
2007a). In order to quantify the degree of EC network assembly, an index of 
interconnectivity was calculated (see Chapter 2 for details on this method), which is a 
value between 0 and 1, with 0 representing an image with all single endothelial cells, 
and 1 representing a completely interconnected network of endothelial cells without any 
single cells. The addition of any single FGF to the medium consistently yielded 
elongated and interconnected ECs by day 7. 
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In the cases of FGF10, FGF7, and FGF10/7, elongated/interconnected EC were 
observed; however there were also many single ECs and complete networks were not 
formed. The index of interconnectivity analysis for FGF10, FGF7 and FGF10/7 yielded 
values ranging from ~ 0.2 - 0.4, however these values were not statistically different from 
each other (Mondrinos et al. 2007a). Widespread, relatively uniform formation of EC 
networks comprising largely interconnected tubular EC assemblies was observed in the 
case of FGF2 and FGF10/7/2, as also reflected by an index of interconnectivity of ~ 0.8 
in both cases (Mondrinos et al. 2007a). Despite the similar index of interconnectivity 
values for FGF2 and FGF10/7/2, the networks formed in FGF10/7/2 cultures were more 
complex, with more and thicker branch points, and consequently more connecting 
tubules compared with FGF2 cultures. In the early experiments, it was observed that 
vascular development in FGF10/7 cultures was restricted largely to regions in proximity 
of epithelium. After examining many experiments, it was concluded that this may be a 
qualitative trend, but in many cases vessels developed in regions not contacting 
epithelium in FGF10/7 conditions. A stronger conclusion is that FGF10/7/2 promotes 
more complete network formation than FGF10/7 alone, in general throughout the 
constructs. In terms of vascular formation in proximity to epithelium, it can be concluded 
that vessels adjacent to epithelium have more prominently formed lumens (Figure 28F), 
although this has not been quantified.  
 
3.3.3 Epithelial-Endothelial Interfacing with FGF Supplementation  
 
 
The epithelial-endothelial interface in developing AFUs was visualized by double staining 
for endothelial cells (isolectinB4) and epithelial cells (cytokeratin or proSpC). Under 
serum-free, baseline conditions (1% ITS), most ECs remained non-elongated rounded, 
single cells, however some interfacing between endothelial cells and epithelial cells was 
observed (arrow in Figure 18A). In the case of FGF10/7/2 supplementation, AFUs were 
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tightly interfaced with and enrobed by interconnected tubular structures comprised of 
ECs (Figure 18B). Penetration of EC capillary-like structures into the clefts of AFUs 
between neighboring epithelial buds was widely observed in FGF10/7/2 cultures (Figure 
18B arrow and Figure 18C arrow). This cleft penetration by endothelial cells is expected 
to be based on either chemotactic or haptotactic cues unique to the cleft environment, 
an issue explored in Chapter 4. 
 
ProSpC staining illustrates the distal epithelial nature of nearly all the cells comprising 
AFUs enrobed by endothelial networks in the FGF10/7/2 condition (Figure 18D). Figure 
18E illustrates the interfacing of proSpC expressing cells comprising bud structures and 
lumenized endothelial structures (Figure 18E arrow). Endothelial tubules remote from 
developing AFUs often appeared as “endothelial cords” that did not contain lumena, 
however in areas directly contacting epithelium, consistent lumen formation was 
observed (Figure 18E and 18F). The phenomenon of endothelial lumen formation 
occurring preferentially in areas contacting epithelium is hypothesized to be attributed to 
increased local levels of SHH protein, based on the known effects of SHH on endothelial 
tube formation (Vokes et al. 2004) and the fact that epithelial cells are the source of SHH 
in the embryonic lung.  
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Figure 18: Visualization of epithelial-endothelial interfacing by fluorescent confocal 
microscopy of whole mount stained constructs. Representative 3-D z-projections (75-100 
one micron thick reconstructed segments) of AFU structures in 7 day constructs 
maintained in either 1% ITS (Panel A) or FGF10/7/2 (Panel B) with epithelial cells 
cytokeratin-labeled (red) and endothelial cells isolectinB4-labeled (green), scale bar = 48 
microns. Note the polarized appearance of the single EC tightly interfaced with the AFU in 
Panel A (arrow). By contrast the AFU in Panel B, viz. in the FGF10/7/2 supplemented 
medium, is enrobed by interconnected EC (arrow). Panel C: Penetration of developing 
epithelial clefts by capillary-like structures (arrow) is visualized by juxtaposition of 
cytokeratin (epithelial, green) and isolectinB4 (EC, magenta), scale bar = 75 microns. In 
FGF10/7/2 cultures, nearly all cells in the AFUs that interface with forming capillary 
networks are distal epithelial in nature (Panels D and E). Panel D: Thin z-projection (20 
micron thick segment) illustrating prosurfactant protein C expression (proSpC, green) of 
cells comprising AFUs and endothelial network formation (isolectinB4, magenta), 
FGF10/7/2, 7 days, scale bar = 150 microns.  Panel E: Single ultra-thin confocal optical 
section (0.1 microns) through an AFU stained with isolectinB4 (EC, magenta) and proSpC 
(green) illustrating tight interfacing between endothelia-lined lumen (indicated by Endo L) 
and a developing distal epithelial bud forming its own lumen (indicated by Epi L), 
FGF10/7/2, 7 days, scale bar = 18 microns. Panel F: A single optical section of isolectinB4 
(EC, green) and DAPI (nuclei, blue) staining in an AFU highlights the formation of 
endothelial lumina in cells contacting epithelium (arrows, note that epithelial cells are 
inferred by the nuclear arrangement of the cells comprising the structure in this image), as 
well as the thin, non-lumenized extensions into the surrounding matrix not contacting 
apparent epithelium (arrowheads), FGF10/7/2, 7 days, scale bar = 47 microns. 
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3.4 Lineage Specific Effects of FGFs: Experiments with the MFLM-4 Cell Line 
 
 
The action of exogenous FGFs on FPC is presumably mediated via specific FGF 
receptors (FGFRs). To confirm the presence of these receptors, FPC cultured overnight 
in 10% FBS in the high density plating configuration described in Chapter 2 were 
immunostained for FGFR1 and FGFR2. The epithelial vs. mesenchymal nature of the 
cells was inferred by morphology, and the endothelial identity within the mesenchyme 
discriminated by isolectinB4 staining. Virtually all FPC, epithelial and mesenchymal, 
ubiquitously express both FGFR1 and FGFR2 protein (Mondrinos et al. 2007a). Both 
endoderm-derived lung epithelium and the lung mesenchyme express FGFR1 and 
FGFR2; however epithelial cells express the “b isoforms”, while cells of mesenchymal 
origin express the “c isoforms”, and this confers ligand specificity (Ornitz et al. 1996, 
Hyatt and Shannon 2004, White et al. 2006, Zhang et al. 2006). Studies using 
engineered cell lines that expressed individual FGFR isoforms revealed that FGF10 and 
FGF7 bind only FGFR2b, while FGF2 binds FGFR1b, FGFR1c, and FGFR2c (Ornitz et 
al. 1996). Based on the known receptor specificity of FGF10 and FGF7, it is likely they 
signal exclusively to epithelial cells through FGFR2b. Similarly, based on known binding 
affinities, it can be inferred that FGF2 signals to both mesenchymal and epithelial 
isoforms of FGFR1 and FGFR2, with preference for mesenchymal isoforms (Ornitz et al. 
1996).  
 
This notion was tested by measuring numbers of epithelial and mesenchymal cells in 
FGF10/7 vs. FGF2 vs. FGF10/7/2 cultures. FGF10/7 induced a statistically significant ~ 
4 fold increase in the number of epithelial cells per AFU (Figure 19), which correlates 
well with the ~ 3 fold increases in AFU area measured in phase contrast images 
(Mondrinos 2007a). By contrast FGF10/7 produced a more modest 1.5-2 fold increase in 
numbers of tropoelastin-positive cells. A ~ 2 fold increase in epithelial cell number per 
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AFU (Figure 19), similar to AFU area measurements (Mondrinos et al. 2007a) was 
induced by FGF2. At the same time, however, FGF2 induced ~ 3.5 fold increase in 
numbers of tropoelastin-positive cells. FGF10/7/2 induced a ~ 4 fold increase in both 
epithelial cells per AFU and tropoelastin-positive cell numbers (Figure 19), apparently 
additively combining the separately observed effects of FGF10/7 and FGF2.  
 
Figure 19: Quantification of epithelial cell numbers comprising AFUs. Measured by 
counting DAPI stained nuclei and mesenchymal cell numbers by counting tropoelastin 
positive cells in 400x microscopic fields of interstitial spaces as described in Chapter 2. 
The data are expressed as fold increase relative to 1% ITS for normalization, * = P < 0.05 
relative to baseline (1% ITS), unless otherwise illustrated by brackets. These data reflect 
comparison of at least 2 samples per condition (ITS, FGF2, FGF10/7 and FGF10/7/2 only), 
from n = 3 independent experiments.   
 
 
 
In order to further test the hypothesis that FGF2 has specific effects in mesenchymal 
cells, while FGF10/7, which bind “b FGFR isoforms” restricted to epithelium do not, 
experiments were performed using the MFLM-4 cell line. MFLM-4 cells are a clonal 
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mouse fetal lung mesodermal cell which has been described as an in vitro model of 
vasculogenesis and angiogenesis (Akeson et al. 2000 and 2001). MFLM-4 cells were 
embedded in 3-D collagen gels at an initial density of 1 x 106 cells/ml and cultured in 
0.2% FBS base medium with either FGF10/7 (25 ng/ml and 10 ng/ml), FGF2 (25 ng/ml), 
FGF9 (25 ng/ml), VEGF-A (50 ng/ml) or 10% FBS (Figure 20). In 3-D collagen gels, the 
MFLM-4 cells form aggregates, but do not migrate or sprout into the surrounding matrix 
when maintained in 0.2% FBS devoid of exogenous growth factors. As expected, 
FGF10/7 did not elicit migratory or sprouting behavior, with indistinguishable morphology 
compared to base medium. FGF2 induced robust sprouting of aggregated MFLM-4 cells, 
as well as marked migration of single, non-sprouting cells into the surrounding matrix, 
indicative of mitogenic, pro-migratory and morphogenic action of this “c-isoform” binding 
FGF. In these experiments, FGF9 was tested as an additional “c-isoform” targeting FGF 
to further probe the hypothesis. Interestingly, FGF9 elicited a similar, but significantly 
less robust effect at an identical dose. This may be due to the fact that FGF9 is a more 
specific ligand binding only FGFR2c with high specificity, while FGF2 is more 
promiscuous and can bind FGFR1c and FGFR2c with high affinity (Ornitz et al. 1996).   
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Figure 20: Effects of various growth factors on sprouting/tube formation behavior in 
MFLM-4 cells, a embryonic lung mesodermal cell line with vasculogenic potential (Akeson 
2000 and 2001). Growth factors were prepared in a 0.2% FBS base medium. As can be 
seen, only FGF2 and FGF9 promote a clear sprouting response, while VEGF-A and 10% 
FBS appear to increase expansion of MFLM-4 aggregates, and in particular VEGF-A 
appears to promote migration away from aggregates, but not sprouting. 
 
 
 
3.5 Discussion 
In line with its definitive role in inducing epithelial branching in vivo (Min et al. 1998), 
FGF10 significantly enhanced bud formation in our in vitro model; an effect that was not 
further enhanced by co-supplementation with FGF7 and FGF2. This supports previous 
findings showing that exogenous FGF10 induces generalized epithelial budding in 
mesenchyme-free cultures in vitro, and rescues alveolar growth in a nitrofen-induced 
model of pulmonary hypoplasia in rats (Acosta et al. 2001). Addition of any single FGF 
resulted in significant epithelial growth and EC elongation/interconnection; however 
robust epithelial budding and uniform EC network assembly were only observed in 
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parallel in FGF10/7/2 cultures. No significant differences in epithelial cell numbers or 
buds per AFU were observed when comparing FGF10/7 and FGF10/7/2 cultures, 
despite increased vascular development and mesenchymal proliferation observed in 
FGF10/7/2 cultures. Importantly, in FGF2 only cultures enhanced mesenchymal 
proliferation was accompanied by uniform endothelial network formation. These cultures 
did not display robust epithelial proliferation and budding, when compared to FGF10/7 
cultures.  
 
FGF2-induced vascular development likely results from a combination of both direct 
effects on EC via FGFRs and indirect effects, e.g. via increased mesenchymal cell 
numbers (Figure 18), which in turn elaborate increased levels of angiogenic factors. It is 
known that pulmonary mesenchymal cell-derived VEGFs contribute to pulmonary 
vascular development (Greenberg et al. 2002). Comparison of network formation in 
FGF10/7/2 vs. FGF2 cultures reveals increased complexity with FGF10/7/2, despite 
almost no differences in mesenchymal proliferation (Figure 18), suggesting that 
enhanced epithelial growth and budding induced by FGF10/7 positively influence 
vascular development. Distal epithelial cells express high levels of VEGF in vivo (Akeson 
et al. 2003), therefore, the combination of increased epithelial and mesenchymal cell 
numbers in FGF10/7/2 cultures likely results in increased levels of proangiogenic 
paracrine signaling. This hypothesis is explored in Chapter 5, when experiments that 
quantified VEGF-A protein production and secretion in response to FGF 
supplementation are described.  
 
The studies on FGF effects in 3-D collagen gel cultures of FPC and MFLM-4 cells 
suggest that the FGFs have lineage-specific effects with FGF10/7 primarily influencing 
epithelial proliferation/budding and FGF2 more potently influencing mesenchymal 
proliferation and eliciting direct effects on endothelial cells, viz sprouting in MFLM-4 
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studies. Taken together, the data suggest that mesenchymal-derived factors, such as 
FGF10/7, play a more significant role in promoting epithelial proliferation and budding 
than a potential vascular-derived signal, and that increased epithelial growth and 
branching positively impacts vascular development. The notion that mesenchymal 
derived-FGFs drive epithelial morphogenesis is in line with the accepted dogma in lung 
developmental biology (Hyatt and Shannon 2004), however there has been a lot of 
recent attention paid to the notion that a vasculature-derived signal may be required for 
branching. Endothelial cells are required for development of the liver (Matsumoto et al. 
2001) and pancreas (Lammert et al. 2003), even prior to establishment of perfused 
vasculature, suggesting an instructive role for the endothelial cell in organogenesis of 
these endoderm-derived tissues. Although such a distinct role has not yet been 
established in lung development, evidence illustrating the potential instructive role of 
vascular development in regulating lung epithelial development has been reported in 
both in vitro (Schwarz et al. 2004) and in vivo systems (Zhao et al. 2005). For example, 
Schwarz et al. (2004) reported that ablation of endothelial network formation by 
endothelial-monocyte activating polypeptide (EMAP) II inhibited formation of quasi-3D 
cystic epithelial aggregates. Importantly, this study highlighted that EMAP II enhances 
the expression of fibronectin but not laminin, which may indicate that EMAP II inhibits 
epithelial development via alteration in the balance of extracellular matrix molecules, 
rather than a vascular-derived signal. Similarly, in murine embryonic lung allografts 
transplanted into the renal capsule, inhibition of vascular development using soluble 
VEGFR1 resulted in decreased vascular and saccular epithelial development (Zhao et 
al. 2005). 
 
More recent experiments using sonic hedgehog (SHH) deficient embryonic lung explants 
demonstrated that stimulation of vascular development with exogenous angiogenic 
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factors, angiopoietin-1 and FGF2, promoted increased epithelial branching 
morphogenesis (van Tuyl et al. 2006), suggesting a potential role of a vascular signal. 
However, since FGF2 also increased mesenchymal proliferation (van Tuyl et al. 2006), it 
is not convincing that it was a direct result of rescued vascular development, rather than 
enhanced mesenchymal signaling. By contrast, there is quite convincing evidence that 
endodermal epithelial signals are required for distal lung vasculogenesis provided by 
tissue recombination experiments demonstrating that differentiation of distal lung 
mesenchymal progenitors into endothelial cells does not occur in mesenchyme only 
cultures (Gebb and Shannon 2004). The issue of whether vascular network formation is 
required for optimal branching is explored in more detail in Chapter 5, where 
experiments in which epithelial morphogenesis was assessed in conditions of 
endothelial network inhibition are described. 
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Chapter 4: Role of endogenous signals in FGF-induced morphogenesis  
 
 
Specific Aim # 2:  Modulation of endogenous signaling by FGFs --- mechanistic 
insights 
 
 
Beyond characterizing the effects of exogenous FGFs (2, 7, and 10) on epithelial, 
endothelial and mesenchymal cell behavior, which represents Specific Aim # 1, the goal 
of Specific Aim # 2 is to determine the effects of exogenous FGFs on the levels and 
distribution of endogenous signaling molecules and to determine the functional 
significance of such molecules, using gain-of-function and loss-of-function studies. The 
molecules studied in Specific Aim 2, each dealt with in a separate sub-Aim, were VEGF-
A, SHH, and TN-C.  
 
 
4.1 Vascular Endothelial Growth Factor-A 
 
 
With endothelial morphogenesis being the primary focus of assessment in this thesis, 
VEGF-A was a logical choice as a potential exogenous signal that may be indirectly 
responsible for FGF-elicited effects on endothelial morphogenesis. The hypothesis that 
endogenous production of VEGF-A protein is required for endothelial network formation 
is the premise of this section. Specifically, it was hypothesized that the degree of 
endothelial network formation would correlate quantitatively with VEGF-A protein levels. 
 
 
4.1.1 Changes in Endogenous VEGF-A Protein Production in Response to FGFs 
  
The first stage of analysis of VEGF-A involved whole mount staining for VEGF-A and 
isolectinB4 across FGF conditions to determine cellular sources of VEGF-A and to 
assess the localization of these sources relative to endothelial cells. VEGF-A wmIHC 
demonstrated widespread localization in epithelial, mesenchymal, and sometimes 
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apparently endothelial cells, although without in situ hybridization it is impossible to 
determine if endothelial VEGF-A was expressed or bound (Figures 21, 22). Intense 
VEGF-A staining was consistently observed in epithelium contacting endothelial tubules 
(Figures 21, 22 top panels). The epithelial identity of the VEGF-A expressing epithelial 
cells, based on morphology without co-staining, was confirmed in early experiments by 
double staining for VEGF-A and the distal epithelial marker proSpC (Figure 22, middle 
panels). A principal finding of these wmIHC studies was that VEGF-A protein is 
expressed at appreciable levels in epithelial structures across conditions; however the 
size and number of these structures vary according to FGF supplementation conditions. 
This pattern is analogous to that observed for proSpC staining across FGF conditions 
and also for SHH staining in epithelial cells across FGF conditions described later in this 
chapter.  
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Figure 21: 3D z-projection of VEGF-A whole mount immunostaining (green) and 
isolectinB4 (magenta) co-staining in an ~ 150 micron thick segment of an FGF10/7/2 
construct. The diversity of VEGF-A sources is clear with VEGF-A protein localizing to all 
compartments of the construct: epithelium (E), and mesenchyme (M) and immediately 
around and within the developing vascular network. 
 
 
 
In addition to the seemingly ubiquitous expression of VEGF-A in the epithelial structures 
across conditions, mesenchymal VEGF-A expression was also detected in both 
interstitial fibroblast-type cells (Figures 21, 22 top right and bottom panels), and also in 
apparent perivascular cells contacting forming vascular structures (Figure 22 bottom 
panels). These results illustrate the diverse cellular sources of VEGF-A in FGF10/7/2 
constructs, providing the first line of evidence that other morphogens, with less 
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pleiotropic roles, and also extracellular matrix are likely responsible for the spatial 
heterogeneity of morphogenesis. 
 
It was decided that qualitative assessment of cellular sources and localization patterns in 
confocal images, in combination with quantitative assessment of total VEGF-A protein by 
ELISA would provide a sufficient conclusion on how FGF10/7, FGF2 and FGF10/7/2 
influence VEGF-A expression. It is generally assumed that VEGF-A protein diffuses out 
of the matrix at equivalent rates across conditions measured by ELISA, that is that 
VEGF-A retention at cell surfaces and in the ECM is equivalent. This is most likely an 
incorrect assumption, and in fact it is entirely plausible that the differences are more 
dramatic than measured by ELISA, since as more organotypic remodeling of the ECM 
occurs, as is true for optimal conditions, it is likely that sequestration of VEGF-A at cell 
surfaces and the ECM in heparin sulfate moieties increases. 
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Figure 22 (previous page, pg. 60): VEGF-A staining patterns in confocal images of whole 
mount stained constructs. Top panels: Single optical sections of VEGF-A whole mount 
immunostaining (green) and isolectinB4 (magenta) co-staining in an FGF10/7/2 construct. 
The left panel depicts an epithelium expressing high levels of VEGF-A protein in contact 
with a nascent endothelial tubule. The right panel depicts a region of an FGF10/7/2 
construct devoid of an epithelium, in which numerous VEGF-A+ interstitial mesenchymal 
cells can be seen, as well as several VEGF-A+ cells directly contacting the vessels. Middle 
panels: Single optical sections of double wmIHC for VEGF-A (green) and proSpC (red), 
along with isolectinB4 (magenta) co-staining in an FGF10/7/2 construct. The left panel 
depicts proSpC+/VEGF-A+ epithelial bud tip cells contacting an endothelial tubule 
(colocalization appears yellow). The right panel depicts a similar structure, but without the 
DAPI stain, demonstrating proSpC and VEGF-A colocalization in epithelial bud cells. Both 
images depict a common feature of VEGF-A staining, apparent intracellular and/or 
intralumenal localization. Bottom panels: Single optical sections of VEGF-A whole mount 
immunostaining (green) and isolectinB4 (magenta) co-staining depicting localization of 
VEGF-A in apparent perivascular cells contacting endothelial tubules. The left panel 
depicts a point of contact near a splitting point in a tubule, while the right panel depicts a 
point of contact at an endothelial “node” from which several branches extend. 
Observation of these VEGF-A positive cells contacting vessels was consistently observed 
in vessels developing away from epithelium.  
 
 
 
Cumulative data for an experimental series looking at VEGF-A levels in cell culture 
media supernatants from FGF10/7/2, FGF10/7, FGF2, 1% ITS, and 10% FBS cultures 
are shown in Figure 23. FGF10/7 and FGF2 conditions yielded total VEGF-A protein 
levels significantly greater than ITS baseline, however with notable decreases relative to 
FGF10/7/2. Comparing the cumulative data for relative numbers of epithelial and 
mesenchymal cell # (Figure 20) and the cumulative VEGF-A ELISA data for ITS, 
FGF10/7, FGF2 and FGF10/7/2 reveals that the ~3-4 fold increase both epithelial and 
mesenchymal cell number correlates well with an ~ 3 fold increase in VEGF-A protein 
secreted into the cell culture medium at a similar time point in the FGF10/7/2 case.  
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Figure 23: Normalized VEGF-A levels in cell culture supernatants across FGF conditions. 
Supernatants were collected following 48 hour feeding periods (0-48 hours and 96-144 
hours) and analyzed by ELISA for mouse VEGF-A (Biosource). Data are expressed as fold 
increase relative to measured values for 1% ITS at each time point. * = P < 0.05 compared 
with 1% ITS at the same time point. 
 
 
4.1.2 VEGF-A Loss-of-function Studies 
 
Having determined that VEGF-A is expressed in epithelial, mesenchymal and also 
potentially endothelial cells, and that total VEGF-A protein correlates with the degree of 
endothelial network formation; experiments were performed with a soluble VEGFR1 
chimeric protein (sVEGFR1) to confirm the functional significance of increased VEGF-A 
in terms of endothelial network formation.  Figure 24 depicts the inhibition of endothelial 
network formation in response to FGF10/7/2 by treatment with a sVEGFR1 (also 
referred to as Flt1-FC). At 96 hours it can be seen that initial endothelial aggregation has 
occurred and some secondary sprouting has begun (Figure 24, top left). Visualization of 
isolectinB4 staining in thin z-projections demonstrates that the degree of endothelial 
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coalescence and network formation decrease with increasing concentrations of 
VEGFR1-Fc, and presumably decreased levels of accessible VEGF-A protein. The first 
effect of sVEGFR1 treatment observed is an absence of the sprouting, but still 
aggregation/cord formation at 500 ng/ml. Then, at higher doses, the true inhibitory effect 
is elicited, ultimately resulting in near complete ablation of network formation at higher 
concentrations (Figure 24). The quantitative relationship between sVEGFR1 dose and 
the previously described endothelial interconnectivity index is shown in Figure 25. 
Concentrations of 1 ug/ml and 2 ug/ml yielded interconnectivity index values that were 
significantly less than FGF10/7/2 without sVEGFR1 treatment. 
 
 
   
Figure 24: Dose response analysis of inhibitory effect of sVEGFR1 (Flt1-FC) treatment on 
endothelial morphogenesis.  
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Figure 25: Dose response analysis of inhibitory effect of sVEGFR1 (Flt1-FC) treatment on 
endothelial morphogenesis as assessed by the previously described index of 
interconnectivity. * = P< 0.01 compared to 0 ug Flt1-FC. 
 
 
 
An additional point of interest regarding VEGF-A loss-of-function, and consequently 
inhibition of vascular development, is how this reciprocally (or directly) affects the 
morphogenic behavior of the epithelium. There have been claims that a vascular-derived 
signal may be responsible for epithelial branching/growth, and some evidence has been 
provided that inhibition of endothelial network formation inhibited epithelial cyst formation 
in vitro (Schwarz et al. 2004), however this study did not demonstrate that the inhibitory 
effect on epithelial cells was specific to an endothelial-derived signal. In order to 
investigate this phenomenon using this system, AFU morphology was assessed in 
phase contrast images from the various sVEGFR1 doses (Figure 26), and AFU area 
quantified as a measure of epithelial growth (Figure 27), as has been shown earlier. The 
results suggest that the presence of appropriate mesenchymal factors (FGF10 and 
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FGF7) drives epithelial growth and morphogenesis, independently of endothelial network 
formation and proximity of epithelium to vascular cells/structures. This supports the 
hypothesis that it is mesenchymal-derived factors that orchestrate epithelial growth and 
branching, while vascular development is dependent on epithelial- and mesenchymal-
derived factors (VEGF-A and others). This assessment is based on morphology, thus it 
is entirely possible that the forming vasculature in FGF10/7/2 constructs plays a “fine 
tuning” role in patterning the growth of the epithelium, and perhaps differentiation state 
among other parameters are influenced. The possibility that the distal vasculature 
patterns the morphology of the terminal alveoli in vivo can not be excluded, however 
based on the known VEGF-A expression patterns of the epithelium and the local matrix 
variations at the epithelial-mesenchymal interface, it seems more likely that the 
developing distal vasculature is patterned by these cues, not vice-versa.   
 
 
Figure 26: Similar epithelial morphology with complete endothelial network inhibition. 
Phase contrast microscopy comparing FGF10/7/2 constructs with or without 1 µg/ml 
sVEGFR1, which was the concentration at which significant inhibition of endothelial 
interconnection and network formation was observed. The left panel, depicting the 
sVEGFR1-treated construct, has AFUs with indistinguishable size and morphology, 
however even in this phase contrast image the decreased degree of endothelial 
networking (no visible tubules) can be observed. 
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Figure 27: AFU area for sVEGFR treatment for the conditions shown above in Figure 26, as 
well as other additional conditions ran in parallel during that experimental series, the 
gross morphological appearance of which is not shown in Figure 42. It can be seen that 
only TN-C inhibition produces an appreciable decrease in AFU area, an issue that is 
revisited using this same figure in a subsequent section on TN-C. * = P < 0.01 vs. 1% ITS, + 
= P < 0.05 vs. TN-C Abs. 
 
 
 
4.2 Sonic Hedgehog 
 
The crucial role of SHH in lung development in vivo is well documented in the literature 
(Bellusci et al. 1997b). In regards to our in vitro system, since FGF10/7/2 dramatically 
enhances epithelial proliferation and branching/budding, it is likely that an epithelial-
derived signal is involved in the enhanced vascular morphogenesis observed --- in 
concert with the direct effects of exogenous FGF2 on these cells. In the previous 
section, epithelial-derived VEGF-A was identified as a likely mediator of vascular 
development. Since VEGF-A is also expressed in mesenchymal cells, and SHH is 
expressed only in the endodermal epithelium,  it was hypothesized that SHH plays a role 
in vascular development with specific effects in proximity to epithelium, viz lumen 
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formation. If SHH signaling is required for FGF-mediated morphogenesis, it is expected 
that cyclopamine treatment will disrupt in vitro morphogenesis stimulated by FGF10/7/2.  
 
4.2.1 Characterization of SHH and Ptc1 expression in 2-D and 3-D 
 
 
Immunofluorescence staining for SHH and Ptc1 was carried out in FPC plated in the 
high density configuration in 2-D (collagen-coated 4-well slides at 1 x 106 FPC/well) 
Figure 28 illustrates that Ptc1 is widely expressed in elongated cells of apparent 
endothelial identity, as well as in apparent diffuse mesenchymal cells found in 
‘condensates’ and also as single cells (Figure 28 top panels). There are also several 
cells that stain at a low level, with a perinuclear pattern. As described earlier, epithelial 
cells present within FPC preparations are found largely as aggregates of varying size 
(Figures 15, 16), with some individual epithelial cells. As expected based on the 
knowledge that SHH is expressed by the endoderm-derived lung epithelium, SHH 
localizes to the aggregated cells (Figure 28 bottom right) and is also observed in 
apparent single epithelial cells with distinct rounded morphology (Figure 28 bottom left). 
These data validate the hypothesis that the SHH signaling pathway plays a role in our 
system by demonstrating that the input material contains an SHH-expressing fraction of 
epithelial cells and SHH-responsive mesenchymal/endothelial cells, the specific SHH 
signaling activity of which will presumably vary according to culture conditions. 
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Figure 28: SHH and Ptc1 expression in briefly cultured FPC. Ptc1 protein localizes to 
flattened mesenchymal cells and elongated apparent endothelial cells (top panels). As 
expected SHH protein localizes to aggregated cells of known epithelial morphology, as 
well as in single cuboidal cells with apparent epithelial morphology (bottom panels). 
 
Initial probing of SHH and Ptc1 expression in 3-D constructs across the FGF 
supplementation conditions: 1% ITS (control), FGF2 (c isoform cells), FGF10/7 (b 
isoform, epithelial cells) and FGF10/7/2 (stimulation of all cell types), was performed by 
wmIHC and 3-D confocal microscopy, as described previously for VEGF-A.  The staining 
pattern for SHH in the epithelium of 3-D constructs across FGF conditions mirrored that 
of VEGF-A, in that epithelial cells seemed to express SHH ubiquitously, as has been 
documented for lung endoderm during organogenesis in vivo (Miller et al. 2001). Figure 
29 depicts SHH expression in epithelium present in FGF10/7/2 and ITS constructs. As 
has been shown previously, the epithelium in FGF10/7/2 constructs grows and buds 
significantly more than with ITS alone, however qualitatively on a per epithelial cell basis 
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the SHH expression appears similar. Therefore, as was the case for VEGF-A, it can be 
inferred that SHH protein levels in the system will increase as the numbers of epithelial 
cell increase, i.e. conditions with FGF10/7 in the medium.  
 
 
 
 
 
 
Figure 29: SHH expression in 3-D constructs visualized by whole mount staining and 3-D 
confocal microscopy. Top Panels: SHH localization in 3-D constructs cultured in either 1% 
ITS or FGF10/7/2, scale bars = 150 microns. Bottom Panels: Double labeling of SHH and 
endothelial cells with isolectinB4. Predominant thickening of vessels in areas of 
interfacing with SHH-expressing epithelium is observed (arrows, bottom left panel, scale 
bar = 150 microns). The bottom right panel shows a high power view of such an area of 
interfacing, lumen formation and thinning/attenuation of the endothelial cell cytoplasm is 
observed, scale bar = 18.75 microns. 
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Returning to an underlying hypothesis about SHH function in this system, it can be 
concluded that endothelial cells closest to the epithelium experience the highest local 
concentrations of SHH protein and that lumen formation is most pronounced in these 
areas. Since SHH has a known role in the conversion of already specified angioblasts 
into vascular tubes (Vokes et al. 2004), it was hypothesized that SHH was responsible 
for the preferential formation of endothelial lumens at points of epithelial contact (Figure 
29 and Figure 17F). Figure 29 (bottom left panel) depicts an epithelial structure being 
penetrated by a developing vascular network, which has been shown previously, 
however here the SHH expression of the epithelium is highlighted. In this image several 
arrows indicate regions of thickening of endothelial tubules, wherein lumen formation is 
most pronounced, which are all in direct contact with SHH-expressing epithelium, while 
most tubules extending away from the epithelium have a clearly smaller diameter (Figure 
29, bottom left, arrows). At higher magnification it can be seen that at these points of 
contact, lumen formation and importantly the morphological feature of extremely thin 
endothelial cytoplasm are observed (Figure 29, bottom right panel). The notion that SHH 
is driving local lumen formation in proximity to epithelium is consistent with reports that 
SHH drives lumen formation in embryonic vessel development (Vokes et al. 2004), as 
well as yielding vessels with increased diameter in adult angiogenesis models (Pola et 
al. 2001, Lavine et al. 2006). 
 
Analysis of the SHH receptor protein, Ptc1, in 3-D constructs across FGF conditions 
revealed an apparent relationship between FGF2 and Ptc1 expression. Preliminary 
quantification of Ptc1+ cell numbers across FGF conditions revealed a ~ 5 fold increase 
in Ptc1+ cells in FGF2 and FGF10/7/2 conditions relative to 1% ITS (see Figure 14, 
example shown for cell counting is Ptc1 staining in 1% ITS vs. FGF2).  When comparing 
ITS and FGF2 constructs; it can be seen that only few cells in ITS express high levels of 
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Ptc1, while in the FGF2 condition there is a much more widespread expression pattern. 
Although the precise effects of FGF supplementation conditions on SHH signaling 
activity have not been determined yet, more substantive insight into the functional 
significance of SHH in the in vitro morphogenesis observed in response to FGF10/7/2 
was sought through gain and loss-of-function studies.  
 
4.2.2 SHH Gain- and Loss-of-Function Studies 
 
In order to gain more insight into the requirement of SHH signaling in FGF-induced 
morphogenesis, loss-of-function studies were performed using cyclopamine. The 
hypothesis that SHH promotes endothelial tube formation was tested in experiments 
investigating the effects of exogenously added SHH in the presence and absence of 
FGF10/7/2.  
 
Experimental Conditions 
1.  ITS 
2.  ITS + 500 ng/ml SHH 
3.  ITS + 500 ng/ml SHH + 5 µM cyclopamine 
4.  FGF10/7/2 
5.  FGF10/7/2 + 5 µM cyclopamine 
6.  FGF10/7/2 + 500 ng/ml SHH 
 
Preliminary dose responses were performed qualitatively due to the costly nature of the 
reagents, particularly the SHH protein. The range of values reported in the literature for 
embryonic lung (White et al. 2006) and heart (Lavine et al. 2006) explants, as well as in 
vitro cell culture experiments (Vokes et al. 2004), were explored. In all of these studies, 
surprisingly, SHH is added to cell culture medium at concentrations of 1-2 µg/ml. Effects 
were observed at 500 ng/ml in our system, perhaps due to the increased diffusivity in 
collagen gels relative to tissue explants, and this was the concentration used for all 
subsequent experiments. It is possible that lower concentrations elicit effects, and also 
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that there are subtle dose responses to SHH in various cellular processes, however 
these experiments focused on the ability of SHH to induce morphogenesis, therefore a 
concentration known to elicit an effect was used repeatedly and the morphological 
outcome assessed.   
 
In terms of cyclopamine inhibition of SHH signaling, there have been reports of 
concentrations of 10 µM in embryonic lung explant experiments (White et al. 2006) and 
in embryonic heart explant preparations as well (Lavine et al. 2006). It was determined 
by preliminary dose response that constructs treated with 1 µM cyclopamine were 
indistinguishable from controls, while those treated with 5 and 10 µM showed a slight 
decrease in epithelial growth, therefore 5 µM was utilized for all subsequent studies. In a 
project focused on SHH signaling, more rigorous dose responses for SHH and 
cyclopamine would be in order, however it is believed that for the purposes of 
determining how SHH relates to other morphogenic signaling activities (FGF, VEGF, 
matrix) in the context of a heterogeneous system, these doses are adequate. 
 
4.2.2.1 Effects in Epithelium 
Figure 30 depict phase contrast micrographs taken at 7 days for the SHH gain and loss-
of-function experimental conditions outlined above. Phase contrast micrographs were 
used to assess epithelial growth by AFU area analysis (Figure 31), similar to the 
experiments in Specific Aim # 1 looking at effects of FGF10, FGF7 and FGF2. The most 
striking observation in these studies is that SHH induces epithelial growth on par with 
FGF10/7/2 (Figure 30), which holds up quantitatively over the series of experiments 
(Figure 31). This finding is actually counterintuitive and was totally unexpected. A similar 
response to FGF2 only treatment was expected, without such dramatic effects on 
epithelial growth, since SHH is known to signal to mesenchymal cells that express Ptc1 
protein in vivo during lung development (Bellusci et al. 1997b). There are at least 2 
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potential explanations for the observed effect on epithelial growth elicited by exogenous 
SHH. First, it is possible that SHH has an unknown signaling activity in epithelial cells. 
Second, and perhaps more likely, it is possible that SHH induces indirect effects through 
increased mesenchymal proliferation which are not observed in FGF2-induced 
mesenchymal enhancement (in the absence of FGF10/7), perhaps due to transcriptional 
differences in the mesenchyme induced by SHH. Nevertheless, as expected for an SHH-
induced effect, parallel cyclopamine treatment returns epithelial growth to levels 
comparable with 1% ITS alone (Figures 30 and 31). 
 
 
Figure 30: Examples of typical morphologies at 7 days for the SHH gain- and loss-of-
function experimental series. All images are magnification100x. 
 
 
 
Another paradoxical finding in regards to this enhanced epithelial growth in response to 
SHH, which will be discussed later in this and the next chapter, is that the mesenchyme 
appears to produce less ECM proteins in response to SHH compared with FGF2, likely 
feeding back negatively on epithelial growth. The mechanism of exogenous SHH-
induced AFU growth remains enigmatic; however, the focus was on SHH-induced 
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vascular development, therefore this issue was not explored further beyond 
characterizing the observed effect.  
 
Figure 31: Quantification of AFU area in SHH gain and loss-of-function experimental 
series. * = P < 0.05 vs. 1% ITS. 
 
 
 
4.2.2.2 Effects on Vascular Development 
 
 
Exogenous SHH protein induces the formation of endothelial networks in serum free 
cultures in the absence of exogenous FGFs, with marked differences in gross 
morphology compared to FGF-induced vessels (Figure 32). 3-D projections of SHH-
induced and FGF-induced networks (Figure 32) illustrate that SHH-induced endothelial 
morphogenesis favors tube formation with increased prominence of lumen formation 
(diameter, uniformity), apparently at the expense of secondary sprouting and 
intussusceptive processes. Quantitative assessment of endothelial interconnectivity 
yielded values on par with FGF10/7/2, albeit slightly lower (Figure 33). This effect is 
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ablated by simultaneous cyclopamine treatment (Figures 32, 33), similar to the inhibition 
of SHH-induced AFU growth by cyclopamine (Figures 30, 31).  
 
 
Figure 32: 3-D visualization of vascular network formation in SHH gain- and loss-of-
function experiments, isolectinB4 whole mount staining, scale bars = 150 microns.  
 
 
 
Despite the dramatic effect of exogenous SHH on in vitro vascular development in the 
absence of FGFs, combination treatment with FGF10/7/2 + SHH did not appear to 
enhance vascular network formation, or morphology, as assessed qualitatively (Figures 
32) and also by quantitative assessment (Figure 33). It appears that FGF10/7/2 + SHH 
induced networks bear more similarity to FGF10/7/2 networks, rather than SHH 
networks, suggesting an apparent “superseding” effect of the FGFs, in combination with 
saturation effects reflecting the inability of the cell to integrate upregulated activity of 
multiple signaling pathways simultaneously. The notion that FGF-induced signaling 
“supersedes” SHH signaling is supported by recent studies in embryonic neural tissue 
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demonstrating that FGF2 can block SHH-mediated neuronal cell fate decisions (Fogarty 
et al. 2007).  
 
 
Figure 33: Quantification of endothelial interconnectivity in the SHH gain and loss-of-
function experimental series. * = P < 0.01 vs. 1% ITS. 
 
 
Similar to the effect observed for cyclopamine treatment in parallel with FGF10/7/2 on 
epithelial morphogenesis, only partial inhibition of vascular network formation was 
observed when SHH signaling activity was inhibited (Figure 32), with a seemingly 
insignificant decrease in quantitatively assessed endothelial interconnection compared 
to FGF10/7/2, but a significant increase relative to baseline 1% ITS on par with 
FGF10/7/2, ITS + SHH and FGF10/7/2 + SHH (Figure 33). This finding is paradoxical 
when considering the fact that FGF apparently potentiates SHH signaling, via promoting 
higher numbers of Ptc1+, SHH-responsive cells (Figure 14 and Lavine et al. 2006).  
These findings imply that the SHH and FGF pathways have both overlap and 
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independence from one another, and apparently that FGF signaling is enough to rescue 
lung morphogenesis (both epithelial and endothelial) in conditions of deficient SHH 
signaling. This notion is supported by experiments demonstrating the ability of FGF2 (in 
concert with Ang1) to rescue mesenchymal, vascular and epithelial development in lung 
explants from SHH deficient mice (van Tuyl et al. 2006).  
 
 
The differences between SHH and FGF-induced vascular networks are described in 
detail in Chapter 5, however some important features of SHH-induced vessels are 
described here. The most obvious feature is increased diameter of vessels throughout 
(not only in regions apparently contacting epithelium) the constructs (Figure 34), and that 
these vessels have a pronounced lumen seemingly throughout the entirety of tubules as 
can be seen in single optical sections (Figure 34). In addition, processes central to 
lumen formation, such as apoptosis of core cells (high amounts of condensed nuclei 
indicative of apoptotic cells in the lumen space) are observed. A key feature of this 
lumen formation and endothelial morphology is the apparent independence of proximity 
to epithelium, as indicated by the absence of local epithelium in Figure 34. This 
observation strongly supports the hypothesis that SHH coming from the epithelium in 
FGF10/7/2 conditions is an inducer of local lumen formation in vessels closest to 
(touching) the epithelium. 
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Figure 34: Morphological features of SHH-induced vessels.  
 
 
 
In order to tie the SHH gain and loss-of-function results to the hypothesis that in vitro 
vascular development depends on total VEGF-A protein levels in the system, VEGF-A 
levels in cell culture supernatants from these experiments were assayed by ELISA as 
described in Chapter 2. The results indicated that SHH treatment in the absence of 
FGFs lead to a marked increase in VEGF-A levels, however there was no additive effect 
observed when SHH and FGFs were added together (Figure 35). Interestingly, 
cyclopamine treatment only partially reduced VEGF-A production in response to 
FGF10/7/2, again suggesting independence of FGF and SHH effects. 
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Figure 35: Cumulative, normalized data for VEGF-A levels in cell culture supernatants as 
measured by ELISA. Of note are the higher values obtained for FGF10/7/2 relative to ITS in 
this series, with 3 fold increase at 48 hours (typically observed at 6 days in other sets of 
experiments), and a 6 fold increase by 6 days, nearly double the previous differences 
observed at that time point. 
 
 
 
4.3 Extracellular Matrix 
 
 
The lung is comprised of both cells and endogenously produced extracellular matrix. 
Therefore, an important ECM molecule in lung development, tenascin-C (TN-C), along 
with formation of epithelial and endothelial basement membranes, was monitored across 
culture conditions.  TN-C is known to play a key role in epithelial branching 
morphogenesis (Gebb et al. 2005), as well as pulmonary vascular development (Ihida-
Stansbury et al. 2004) and is thus an important molecule to characterize and manipulate 
when studying lung development in an in vitro system. It is hypothesized that TN-C 
deposition and incorporation in and around epithelial and endothelial basement 
membranes in part mediates vascular and epithelial morphogenesis and interfacing. A 
80 
logical of extension of the hypothesis that focal deposition of TN-C is functionally 
significant, is that inhibition of TN-C with neutralizing antibodies will reduce vascular 
morphogenesis and epithelial sacculation. There are numerous other essential ECM 
molecules, such as fibronectin (FN) and laminin (LM), both of which were investigated; 
however, the primary emphasis was to gain a better understanding of TN-C involvement 
in lung morphogenesis.  
                    
4.3.1 TN-C localization studies 
First, whole mount IHC and confocal analysis of TN-C distribution within constructs 
generated across FGF supplementation conditions was performed (Figure 36, see also 
appendix).. In all of the numerous experiments analyzed in which wmIHC for TN-C was 
performed, no instances of cytoplasmic localization of TN-C in epithelial cells was 
observed, however TN-C protein was frequently found in and around epithelial basement 
membranes and in forming clefts (Figure 36A). An important limitation of the TN-C data 
set is a lack of in situ hybridization data directly demonstrating which cell types are 
responsible for synthesis and deposition of the TN-C, however extensive confocal 
analysis has revealed consistent cytoplasmic staining of TN-C protein within some 
endothelial cells and also in the cytoplasm of surrounding mesenchymal cells, as can be 
seen in several of the following micrographs. This topic will be addressed in more detail 
later in this chapter. Despite the lack of in situ hybridization data, it is a reasonable 
assumption that TN-C is produced by the mesenchymal and endothelial, but not 
epithelial cells, however TN-C obviously impacts epithelial cells based on its interactions 
with the basement membrane of these cells (Figure 36A). Figure 37 shows convincing 
evidence that TN-C protein plays a functional role in several endothelial behaviors, such 
as coalescence and “node formation” and branch formation away from nodes (Figure 37 
left panel), as well as in guiding extending endothelial tips (Figure 37 right panel).  
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Figure 36: TN-C localization relative to epithelial and endothelial cells. Panel A indicates a 
prominent feature observed in FGF10/7/2 constructs, TN-C localization in and around the 
basement membrane of budding epithelial cells. Panel B shows TN-C expression in the 
matrix, and apparently the cytoplasm of the surrounding stromal cells, around a nascent 
endothelial tubule.  
 
 
 
 
Figure 37: Confocal Z-projections of wmIHC for TN-C with isolectinB4 staining of EC: 
localization of TN-C protein in the extracellular matrix surrounding a “node” structure from 
which several tubules extend (left panel, scale bar = 24 microns) and also surrounding 
extending tips (right panel, scale bar = 12 microns). 
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4.3.2 TN-C loss-of-function studies 
 
 
4.3.2.1 Effects on epithelial morphogenesis  
 
Inhibition of TN-C function using polyclonal antibodies as previously reported for the 
Matrigel angiogenesis assay (Ihida-Stansbury et al. 2004) required considerable 
experimental optimization. This was due to the increased three-dimensionality and 
associated diffusion considerations. This dose optimization is described in Chapter 2, 
however it is reiterated here that inhibition of function required a concentration of 20 
µg/ml TN-C antibodies mixed BOTH into the gel at the beginning of the experiment, and 
also replenished in the media at the same concentration when feeding. Also, as 
described in Chapter 2, the 10% FBS overnight incubation was omitted to avoid antibody 
losses, without any overtly noticeable effects.  
 
Treatment with TN-C antibodies reduced the growth of AFUs (Figure 38 and AFU area 
measurements in Figure 39), as well as altering the morphology of the epithelial cells 
lining the AFUs (Figure 38). It can be seen in Figure 37, which compares AFUs growing 
in FGF10/7/2 vs. FGF10/7/2 + TN-C Abs that the AFUs are slightly smaller and more 
circular. AFUs in TN-C Ab treated samples also display a more cystic morphology, with 
more dilated lumens and also seemingly more attenuated (thinned-out) epithelium 
(Figure 38). The more cuboidal/columnar morphology of cells lining AFUs and more 
invasive budding behavior in the positive control conditions is apparent. The mechanism 
remains enigmatic, however it is likely related to altered epithelial adhesion to the 
basement membrane, based on disruption of TN-C participation in basement membrane 
dynamics. Also, the decrease in TN-C accessibility to surrounding mesenchymal cells 
may alter their phenotype. 
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Figure 38: Normal fluorescence microscopy of wmIHC for cytokeratin (green) in TN-C loss-
of-function experiment. Top row is positive control (not normal Rb IgG treated, although 
this was done in subsequent experiments with similar results to FGF10/7/2 without Rb IgG 
addition). Bottom panels: cropped images showing the differences in epithelial budding 
behavior on the AFU level, and also alteration in epithelial cell morphology on a single cell 
level, in response to TN-C neutralization. 
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Figure 39: AFU area for sVEGFR treatment and TN-C Ab treatment, which were conducted 
in parallel. It can be seen that only TN-C inhibition produces an appreciable decrease in 
AFU area. * = P < 0.01 vs. 1% ITS, + = P < 0.05 vs. TN-C Abs. 
 
 
 
4.3.2.2 Effects on endothelial morphogenesis  
 
Neutralization of TN-C with polyclonal antibodies has a marked, but not complete 
inhibitory effect on endothelial interconnectivity and overall network formation (Figures 
40 and 42). In the example shown in Figure 40, endothelial network formation occurred 
at more accelerated rate than normal by 96 hours in FGF10/7/2 condition (Figure 40, top 
panels), however the coalescence of endothelial cells into aggregates/cords, and 
apparently the secondary sprouting of endothelial tubes that do form, are both inhibited 
significantly by a sufficiently high dose of TN-C neutralizing antibodies (Figure 40, bottom 
panels). Importantly, the positive controls here include a normal rabbit IgG mixed into the 
culture system at the same times and same concentrations (20 µg/ml) as the neutralizing 
antibodies. The quantitative effect of TN-C neutralization on endothelial network 
formation is shown in Figure 41, indicating a decrease in interconnectivity index from ~ 
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0.85 in FGF10/7/2 constructs treated with normal rabbit IgG to ~ 0.6 in FGF10/7/2 
constructs treated with polyclonal rabbit antibodies against TN-C. 
 
 
Figure 40: Inhibition of endothelial elongation, interconnection and network formation by 
TN-C neutralizing antibodies. The top row of images depicts representative confocal 
images from 3 separate constructs in a single experiment treated with FGF10/7/2 + 20 
µg/ml normal Rabbit IgG mixed into the gel and the media, 96 hours. The bottom row 
depicts similar representative confocal images from 3 separate constructs in a single 
experiment treated with FGF10/7/2 + 20 µg/ml TN-C antibodies in the gel and media, 96 
hours. The scale bars are difficult to see, the top left image has an added scale bar, 150 
microns, all scale bars = 150 microns.  
 
 
 A very interesting observation regarding the TN-C inhibition studies is the difference in 
the morphology of single endothelial cell compared to VEGF-A inhibition experiments. In 
the sVEGFR1 experiments, single endothelial cells inhibited from forming networks 
exhibited a round morphology, perhaps due to cell death (Figure 42). Totally contrasting 
morphology is observed with TN-C antibody treatment, upon which single endothelial 
cells have morphology indicative of viable, well-adhered cells (Figure 40, bottom panels). 
The adhesion state of the single cells appears to be enhanced, and this may be related 
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to the role of TN-C in promoting a motile state in cells by altering the focal adhesion 
status (Midwood and Schwarzbauer 2002) and also modulating interactions with other 
matrix proteins such as fibronectin (Midwood et al. 2004). It is hypothesized that TN-C 
“masking” decreases the motility and stabilizes the local adhesions of endothelial cells, 
partially thwarting aggregation/coalescence events and secondary sprouting which also 
requires cell motility. 
 
 
Figure 41: Part of Figure 24 shown earlier in the section on VEGF-A. The rounded 
morphology of the non-elongated/interconnected EC observed upon VEGF-A inhibition is 
clearly illustrated. 
 
 
 
 
Figure 42: Quantitative assessment of TN-C inhibition of endothelial network formation 
behavior using the calculated endothelial interconnectivity index, ** = P < 0.01.  
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4.3.3 TN-C gain-of-function experiments 
 
 
TN-C addition experiments indicated a slight “rescue” effect in the absence of FGFs, 
while addition of TN-C in the presence of FGFs either had no apparent effect or in some 
cases suggested an inhibitory effect on endothelial network formation, perhaps through a 
“de-adhesion” phenomenon negatively impacting endothelial cell motility. Examples of 
typical micrographs from TN-C gain-of-function experiments are included as Appendix 
material (see Figures A3 and A4). It is concluded that the presence of TN-C protein in 
high amounts does not drive vascular morphogenesis, but rather that the precise 
locations of endogenously produced TN-C function to “fine tune” vascular development. 
 
4.3.4 TN-C and basement membrane studies 
The distribution of TN-C relative to epithelial and endothelial basement membranes (BM) 
was characterized, with emphasis on optimal conditions and the goal of providing novel 
mechanistic information on how TN-C modulates epithelial and endothelial 
morphogenesis, and interfacing between these cell types. 
 
4.3.4.1 Endothelial basement membranes and TN-C 
 
 
Figure 43 depicts typical colocalization patterns of laminin (LM) and TN-C around 
endothelial cells in already formed “cords” (top panels) and also sprouting tips (bottom 
panels) in an FGF10/7/2 construct at 7 days. Figure 43 (top panels) illustrates that both 
TN-C and LM localize to the cytoplasm of both endothelial and perivascular cells. The 
top panels of Figure 43 demonstrate the presence of TN-C in the endothelial BM with 
“frills” of TN-C extending beyond in stabilized tubes. More prominent localization around 
sprouting tips of endothelial cells was shown earlier in Figure 37 and also in Figure 43 
(bottom panel). In Figure 43 the importance of the surrounding support cells in the 
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production of the TN-C is apparent, particularly at the leading edge of extending tips 
(Figure 43 bottom panel). 
 
 
 
 
 
 
 
Figure 43: Colocalization of TN-C, LM and endothelial cells (isolectinB4). Left panel: an 
endothelial cord, with a covering perivascular cell illustrates a laminin-rich basement 
membrane beneath the endothelial cells, and also LM-positive cytoplasm in the 
perivascular cell. Middle panel: same image with the TN-C exposure instead of the 
isolectinB4 exposure illustrates TN-C protein in the basement membrane, the cytoplasm of 
the perivascular and endothelial cell, as well as in a “frill” of varying thickness that 
extends beyond the basement membrane. Right panel: a growing tip with TN-C and LM in 
the basement membrane (yellow), except at the growing tip where the LM signal 
decreases; also visible is a prominent TN-C “frill” right in front of the growing tip, with 
another important feature being the presence of both LM and TN-C protein in the 
cytoplasm of the surrounding stromal/perivascular cells.  
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4.3.4.2 Epithelial basement membranes and TN-C 
 
Figures 44 and 45 depict the preferential localization of TN-C and not LM in the clefts of 
developing AFUs in FGF10/7/2-treated constructs following 7 days of culture. The 
apparent “epithelial-penetrating” mesenchymal cell source of this TN-C deposition is 
depicted in Figure 45, while the diversity of observed basement membrane stains in 
regards to the localization of TN-C and LM, even within a single structure, is shown in 
Figure 46. Figure 44 depicts TN-C, LM and DAPI whole mount staining in a 3-D 
projection of an entire AFU. Single channel exposures (Figure 44, right panels) 
demonstrate that LM is predominantly in the basement membrane beneath the most 
basal cells, while TN-C protein localizes robustly to apparently forming clefts between 
adjacent epithelial buds. 
 
 
  
Figure 44: Colocalization of TN-C and LM in a budding AFU (epithelial structure), confocal 
z-projection, 150 microns thick, scale bar = 37.5 microns. 
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In an optical section (Figure 45), it can be seen that TN-C is present “within” the 
epithelium, in clefts, apparently produced by mesenchymal cells whose nuclei can be 
readily seen with TN-C rich cytoplasm in the clefts (Figure 45, arrows). Interestingly, 
there is a complete lack of LM protein in the cleft structures. 
 
 
Figure 45: Single optical section taken thru an AFU similar to that depicted in Figure 44.  
 
 
 
Figure 46 illustrates the numerous BM “states” observed around the clefts of developing 
AFUs. As described in the panel, basement membrane states in which intact separate 
layers of TN-C and LM are observed, as well as apparently proteolysed regions where 
the proteins appear globular (arrow without accompanying text in Figure 46), and the 
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reproducible trend of increased TN-C in clefts, but not LM, in FGF10/7/2 treated 
constructs. These observations suggest that TN-C is specifically involved in the 
morphogenic events that give rise to the distal lung architecture, specifically epithelial 
sacculation and cleft formation, and potentially epithelial-endothelial interfacing, viz. 
blood-air barrier formation.  
 
 
Figure 46: Characterization of different basement membrane states within morphogenically 
active AFUs, single optical section, scale bar = 9 microns.  
 
 
 
4.3.4.3 Endothelial-Epithelial Interfacing and TN-C 
 
 
In addition to the clear roles of TN-C in the matrix dynamics of endothelial morphogenic 
processes (Figure 43), as well as in epithelial budding, apparently with a distinct role in 
cleft formation (Figure 44-46), a role for TN-C in epithelial-endothelial interfacing was 
also identified (Figures 47). A striking absence of LM in the TN-C rich region between 
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interfaced epithelial and endothelial cells suggests that TN-C may be a transient 
“provisional” matrix protein which facilitates the motile events needed for tight 
interfacing, but then disappears eventually if the cells were to form a blood-air barrier. It 
is intuitive that laminin would not be a good candidate as a provisional matrix protein for 
such a role, since it LM adhesions have known stabilizing effects in both cell types. The 
current hypothesis is that the following sequence of events leads to the formation of the 
epithelial-endothelial interface: epithelial and mesenchymal cells establish an interface, 
mesenchymal cells deposit TN-C protein preferentially in clefts and around the epithelial 
BM, endothelial cells then preferentially migrate in regions of enhanced TN-C deposition, 
viz. around the BM and in clefts. Finally, in regards to establishment of the blood-air 
barrier in vivo, TN-C is a logical candidate as a transient mediator of the adhesion 
events required for initial interfacing, then being degraded to allow for membrane contact 
between the alveolar epithelium and capillary endothelium. 
 
 
Figure 47: TN-C localizes in the intervening space between interfaced epithelial and 
endothelial cells much more prominently than laminin. A TN-C rich cleft devoid of laminin 
is immediately below the endothelial cell. Note the robust staining of LM on the side of the 
endothelial cells touching the stroma, but complete lack on the side touching the 
epithelium (left panel). 
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4.4 Discussion: Mechanisms Underlying Morphogenesis 
 
Epithelial-mesenchymal signals are essential to orchestration of lung development 
(Hyatt and Shannon 2004), and FGFs are among the main reciprocal signals in these 
tissue interactions. All events elicited by exogenous FGFs occur first through binding 
and activation of signaling in cell lineage (and ligand specific) specific FGF receptor 
tyrosine kinase proteins.  The most important effect of exogenous FGFs is maintenance 
of cell viability and, especially at the cell densities used in these constructs, proliferation 
of both epithelial and mesenchymal cells which allows for the progression of natural 
molecular interactions that occur during lung development, such as epithelial and 
mesenchymal VEGF production, matrix remodeling/assembly, and SHH signaling.  
 
Taken together, the findings of the FGF experiments (Chapter 3) and the VEGF-A loss-
of-function experiments suggest that FGF and VEGF signaling are required for in vitro 
vascular development in the context of the particular culture conditions implemented, i.e. 
initial cell densities. This is based on the observation that appreciable vascular 
development does not occur in the absence of exogenous FGFs (Figure 18), and that 
VEGF blockade with sVEGFR was the only loss-of-function experiment that 
demonstrated near complete inhibition of vascular development in the presence of 
FGF10/7/2 (Figure 24 and 25). SHH was shown to promote lumen formation (Figures 29 
and 34) and the was able to induce formation of vascular structures in the absence of 
FGFs, however there appeared to be deficiencies in endothelial cell motility, viz. 
sprouting angiogenesis, in these conditions (Figures 34 and 56). By contrast, TN-C 
protein was consistently observed in the matrix surrounding sprouting tips in FGF-
induced vascular networks (Figures 37 and 43), both of which are absent in SHH-
induced vessels (Figure 57). Interestingly, a exclusivity of LM function and TN-C was 
identified, with LM being found in all epithelial and endothelial BMs, and TN-C 
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preferentially localizing at “morphogenic hot spots”, i.e. clefts of branching epithelium 
(Figures 44-46), where LM appears to be transiently absent. TN-C was shown to have a 
functional role in the epithelial bud formation process (Figure 38) and vascular 
development (Figure 40), as previously described in the literature. As a novel finding, 
TN-C appears to serve as a provisional matrix protein to replace laminin at the epithelial-
endothelial interface (Figure 47). In summary, the novel mechanistic findings regarding 
distal lung vascular development not previously described in the literature are that SHH 
potently influences vascular lumen formation in proximity of epithelium and that TN-C 
mediates epithelial-endothelial interfacing in developing alveolar structures. Taken 
together, VEGF and FGF signals appear to play pleiotropic roles in the epithelial-
mesenchymal-endothelial interactions, while SHH and TN-C appear to play transient, 
“fine tuning” roles that function to sculpt the distal lung vasculature.  
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Figure 48: Schematic representation of the functional roles of FGF signals (limited to FGF2 
here for simplicity), VEGF, SHH and ECM modulation identified in this thesis. The details 
are described in the above text. 
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Chapter 5: Engineered Fetal Lung Tissue Constructs as a “True” In Vitro Model of 
Organ-specific Vascular Development 
 
An additional goal of this thesis was to develop these constructs as models of vascular 
development in the context of the lung. The three ways that blood vessels are believed 
to form are: vasculogenesis, sprouting angiogenesis and intussusception, also known as 
splitting angiogenesis. These processes, along with interactions with tissue-specific 
parenchymal and perivascular cells are required to truly model organ-specific vascular 
development. Each of these elements and how this system can be used to study each in 
the context of distal pulmonary vascular development are described below. 
 
5.1 Vasculogenesis 
 
Vasculogenesis is defined as the differentiation of immature mesodermal cells into 
angioblasts (Gilbert 2005). Some in vitro models described in the literature, such as in 
the MFLM-4 vasculogenesis/angiogenesis assay developed by Ann Akeson (Akeson et 
al. 2001), are often referred to as “models of vasculogenesis”, although these models do 
not actively demonstrate the conversion of immature mesenchymal cells into 
differentiated endothelial cells. Though we observe vascular plexus formation from 
dispersed cells, we did not characterize differentiation of mesodermal precursor cells 
into EC during the formation of vascular structures. Therefore we do not whether 
progressive EC differentiation is occurring or if observed network formation reflects 
reconstitution from already differentiated EC, making assessment of ongoing 
vasculogenesis impossible to separate from simple ‘networking’ without focusing on a 
panel of endothelial differentiation markers.  
 
 
 
 
97 
5.2 Sprouting Angiogenesis 
 
 
During vascular development, following formation of the primitive vascular plexus by 
vasculogenesis, the vasculature of a given tissue is then remodeled by angiogenic 
processes, viz. establishment of new blood vessels from pre-existing vascular structures 
(Risau 1997). The most commonly studied angiogenic process is sprouting 
angiogenesis, which initiates the establishment of a new vessel from a pre-existing 
vessel by a combination of endothelial cell migration and proliferation (Risau 1997). An 
important biological process in angiogenesis relevant to the data discussed in this 
chapter is the extension of filopodia in angiogenically “activated” endothelial cells. We do 
not have real time video microscopy, but based on analysis of static images at 24 hours 
and 7 days, not necessarily in parallel in repeated experiments, but over several series 
of experiments looking at these time points for other reasons, it has been inferred that 
the endothelial cells present in the culture exist initially largely as individual cells, which 
then organize into multicellular aggregates/cords which subsequently coalesce. An 
additional phase of largely sprouting and vessel splitting (intussusception) occurs, 
seemingly after the initial 72-96 hour period. Elucidating the precise time scales and 
sequences of vascular morphogenic events would require real time video microscopy, 
rigorous time course analysis, and a project focused on collecting specifically these data. 
Shown below in Figure 49 are examples taken from a 7 day construct cultured with 
FGF10/7/2, displaying a frequently observed sprouting activity establishing secondary 
tubules within a forming vascular plexus.  
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Figure 49: Characterization of sprouting angiogenesis in FGF10/7/2 constructs cultured for 
7 days via wmIHC for isolectinB4, and 3-D laser scanning confocal microscopy. Following 
7 days, vascular networks have formed and are still actively sprouting/remodeling.  Panel 
A: 3-D z-projection, in the upper portion of the image (arrow next to ‘vasculogenesis?’) a 
group of aggregated cells that display a more compacted morphology, rounded nuclei and 
detectable, but weak, isolectinB4-positive staining, are seen forming a seamless interface 
with cells that display the intense isolectinB4 staining and elongated cellular/nuclear 
morphology typically observed. In addition, 2 points of sprouting are indicated by arrows 
and ‘sprouting’. Panel B: Sprouting angiogenesis in a 3-D z-projection depicting a portion 
of a node in a vascular plexus displaying multiple angiogenic sprouts, 7 days culture in 
FGF10/7/2. 
 
 
5.3 Intussusceptive Angiogenesis 
 
 
The often overlooked form of angiogenesis, intussusception is the process whereby a 
new blood vessel is created by the splitting of an existing blood vessel in two (Djonov et 
al. 2003). Of the 3 major vascular developmental processes, intussusception is by far 
the most poorly characterized, with most in vitro and in vivo models focusing on 
sprouting angiogenesis. Intussusception is important because it is a reorganization of 
existing cells which allows a vast increase in the number of capillaries without a 
corresponding increase in the number of endothelial cells. Intussusception is likely an 
important process in this system since it is unlikely that sprouting alone could give rise to 
the number of tubules observed in FGF10/7/2 treated constructs at 7 days. The demand 
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on endothelial proliferation would be very high; therefore, intussusceptive vessel splitting 
was hypothesized to be a primary mode of vascular network “amplification”, as is 
observed in the vertebrate lung (Makanya et al., 2007). The intussusceptive process 
involves the establishment of “tissue pillars”, the formation of which is believed to involve 
myofibroblast invasion and local matrix heterogeneity (Djonov et al. 2000 and 2003, 
Makanya et al. 2007). Figure 50 below taken from Makanya et al. (2007) illustrates 
intussusceptive vessel splitting in serial sections of embryonic chicken lung.  
 
 
Figure 50: Taken from Makanya 2007, histological characterization of intussusceptive 
vessel growth in embryonic chicken lung. Shown are serial sections in which a single 
vessel lumen (left panel, arrow) is split into 2 lumens by formation of a “tissue pillar” 
(middle panel, arrowheads), which apparently involves myofibroblasts (right panel, inset).  
 
Figures 51 and 52 demonstrate evidence of intussusceptive “vessel splitting” processes 
in confocal micrographs. Figure 51 illustrates the formation of a “tissue pillar” in a 
splitting vessel perpendicular to the plane of section, similar in nature to the example 
shown in Figure 50 from Makanya et al. (2007). Figure 52 depicts a similar vessel 
splitting process; however, the vessel split is occurring parallel to the plane of section. 
Interestingly, fibronectin (FN) appears to play a key role in facilitating intussusceptive 
processes, as evidenced by the intense focal deposition of FN observed at locations of 
vessel splitting (Figures 51 and 52). However, clear elucidation of the role FN plays in 
intussusceptive, as well as other vascular morphogenic processes will require rigorous 
analysis, similar to that carried out for TN-C in this thesis. 
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Figure 51: Characterization of an apparent intussusceptive vessel splitting process, in 
which a single endothelial lumen is split in two by establishment of a “tissue pillar”, by 3-D 
confocal microscopy. This is not a time lapse series, but rather images from a z-stack 
documenting an already formed structure following 7 days in FGF10/7/2. These images 
represent optical cross-sections of a vessel structure identified by isolectinB4 (pseudo-
colored blue for RGB stack merge function in ImageJ). Arrows indicate walls of the 
endothelial tube which appear to have pinched in and given rise to two separate 
endothelial tubes of smaller diameter. Co-staining for laminin (green) and fibronectin (red) 
illustrates that local change in matrix content, particularly increased levels of fibronectin 
deposition in the area of vessel splitting, plays a key role in the intussusceptive 
processes. 
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Figure 52: Intussusceptive angiogenesis as a mode of secondary vascular development: 
identification of vessel splits. This image is a single confocal optical section through a 
vessel structure generated FGF10/7/2 media for 7 days co-stained for isolectinB4 
(magenta), laminin (green) and fibronectin (red). The long thin arrow indicates the “wedge” 
of fibronectin deposited at a point of vessel splitting, which did not appear to occur by 
sprouting, but rather by intussusception. Interestingly, there is not appreciable fibronectin 
deposition at points of vessel sprouting, indicated by large arrowheads. 
 
 
 
5.4 Interactions with Parenchymal and Perivascular Cells 
 
Often lacking in many in vitro models of microvascular development is the incorporation 
of perivascular/stromal cells, which are absolutely essential to the stabilization and 
maturation, as well as orchestrating development of, microvasculature in vivo via 
paracrine factors and matrix elaboration. In addition to stroma and perivascular cells, 
microvasculature within the body develops within the context of a tissue parenchyma. 
Parenchymal cells are often responsible for orchestrating the patterning of microvascular 
development, particularly the epithelia of glandular organs, as has been demonstrated 
for the beta cells of the pancreas (Nikolova et al. 2006) and also the distal epithelial cells 
in the lung alveoli (Akeson et al. 2003). In addition, it is often the parenchymal cells that 
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respond to ischemic stress by secreting VEGF and stimulating vascular healing, as has 
been shown for lung epithelial cells (Compernolle et al. 2002). In light of the 
considerable heterogeneity of the endothelium (Aird 2007), in vitro models of vascular 
development will require the incorporation of organ-specific parenchymal and 
stromal/perivascular cells in order to achieve organ-specific “angio-architectural” and 
“angio-phenotypic” characteristics. This model has been used to characterize the role of 
both fetal lung epithelial (parenchymal) and perivascular/stromal cells in vascular 
development (Chapters 3 and 4), specifically characterizing the effects of factors and 
matrix secreted by these cells, and is therefore a novel, and groundbreaking in vitro 
system for studying lung-specific vascular development. 
 
5.5 Lumen Formation 
 
 
Besides organization of the endothelial cells into the architecture of a network, 
angiogenic remodeling processes, and the interactions with both perivascular cells and 
parenchymal cells; an in vitro model of vascular development should facilitate study of 
lumen formation. It has been demonstrated in Chapters 3 and 4 that the endothelial 
structures present within the constructs do often display lumen formation preferentially in 
proximity to epithelium in exogenous FGF10/7/2 conditions, and seemingly 
independently of position relative to epithelium in exogenous SHH conditions.  The 
precise mechanisms of this process remain enigmatic, however there are at least 3 
major accepted modes of lumen formation that can be demonstrated: 1 - Selective 
apoptosis of “core cells” in the solid cords/aggregates formed by vasculogenesis, 2 - 
Fusion of intracellular vacuoles, which may actually be connected to the prior mode, that 
is via engulfment of dead cells, and 3 - Folding or invagination events that involve a 
portion of the plasma membrane then giving rise to the apical lumen surface, similar to 
intussusception in already formed tubes. 
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The process of tube formation has been defined in general to encompass at least 3 
major processes in the cells forming the tubes (Lubarsky and Krasnow 2003, Hogan and 
Kolodziej 2002): increased intercellular contacts between the forming cells, 
establishment of apical-basal polarity, and interactions with surrounding matrix. The first 
can be considered to be the coalescence phase of the network formation, while 
establishment of apical-basal polarity can be monitored by examining basement 
membrane formation, which also involves the matrix interactions that will “stabilize” the 
tube. In addition, basement membrane formation with an apical surface facing a lumen 
devoid of matrix proteins in the forming vascular networks is a common feature, which 
indicates the establishment of apical-basal polarity. The third process, interactions with 
the matrix influencing lumen formation, has been demonstrated in this system by 
qualitative assessment of basement membrane structure and composition (relative 
amounts of laminin and tenascin), revealing that the BM state varies according to the 
state of the vessel (Chapter 4, Figures<).  
 
In addition to the three fundamental cellular processes involved in tube formation 
reviewed by Lubarsky and Krasnow (2003), endothelial vascular lumen formation is 
known to involve selective apoptosis (Meyer et al. 1997, Duval et al. 2007) and 
formation/fusion of intracellular vacuoles (Kamei et al. 2006). A recent study which 
described transgenic mice expressing the anti-apoptotic protein Bcl2 under the Tie2 
promoter, which theoretically confers apoptotic resistance in the developing angioblasts, 
demonstrated that large vessels (aortic arches) form normally, but that the vessels of the 
placental labyrinth, as well as the developing microvasculature of the embryo was 
dysmorphic and displayed impaired lumen formation, resulting in the transgenic mice 
dying in the second half of gestation (Duval et al. 2007). This indicates that selective 
apoptosis appears to be necessary for lumen formation and vessel maturation in the 
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small vessels, but perhaps other processes which involve cell movements, but not 
selective apoptosis, may be at the core of de novo formation of large diameter vessels. 
Our data suggest, based on assessment of cellular/nuclear morphology, that apoptosis 
appears to be a widespread event leading to lumen formation in the forming 
microvasculature within engineered fetal lung tissue constructs (Figure 53). The 
appearance of “nuclear blebs” or “apoptotic nuclei”, within forming lumen spaces in 
commonplace. Currently we do not have well documented immunohistochemical 
detection of apoptosis, nevertheless, morphological features such as condensed and 
fragmented nuclei are generally accepted features of apoptotic cells (Dini et al. 1996, 
Bonnano et al. 2000 and 2002, De Nicola et al. 2006).  
 
 
Figure 53: Depiction of apparent apoptosis of core cells potentially leading to lumen 
formation, FGF10/7/2, 7 days. Note the closed nature of the tubule proximal and distal to 
the apoptotic blebs indicated by the arrows. Pictured again here is the prominent feature 
in FGF-induced vessels of perivascular coverage (arrowheads). 
 
 
 
In addition to selective apoptosis, vacuole formation was cited in seminal papers in 1980 
by Folkman and Haudenschild, on in vitro models of angiogenesis, as being a primary 
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mode of lumen formation by endothelial cells in 3-D cultures in vitro. It has been long 
postulated, but very difficult to document that vacuole formation contributes to lumen 
formation in vivo. Recently it was explicitly shown for the first time by intravital video 
microscopy of lumen formation in the intersegmental vessels of the zebrafish (Kamei et 
al. 2006). In the same study light video microscopy of endothelial cells in collagen gels 
validated the notion by Folkman and many others that this mode of lumen formation 
contributes to tube formation in vitro (Kamei et al. 2006). The formation of vacuoles has 
been shown to be a pinocytic event (Figure 54, Kamei 2006). 
 
 
Figure 54: Taken from Kamei et al. (2006). Schematic model of how formation and 
intracellular fusion of endothelial vacuoles leads to lumen formation. 
 
In our system we do not yet have characterization of vessel morphogenesis by real time 
microscopy, however as was the case for intussusception, there is strong suggestive 
morphological evidence based on static images and z-stacks collected by 3-D confocal 
microscopy that vacuole formation, and fusion, is occurring in the lumen formation 
process. As was observed for several biological processes occurring in this system, they 
are asynchronous relative to in vivo development, and vessel structures in static images 
are found in 3 general states of lumen formation, the first being solid with no lumen 
formation, the second being in the process of lumen formation (vacuole-laden cytoplasm 
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and/or high numbers of apoptotic nuclei), and finally complete lumen formation with 
attenuated, thinned-out cytoplasmic morphology of the lining endothelial cells. Figure 55 
below depicts a typical example of apparent vacuole fusion in a “node” of a formed 
plexus, where the spaces previously occupied by the core cells appear to be being 
replaced by several large intracellular vacuoles, which appear as void spaces in the 
image. Regions of apparent fusion of adjacent vacuoles, as inferred by cytoplasmic 
isolectinB4 staining, are indicated by a series of arrows in Figure 55 (right panel).  
 
  
Figure 55: Vacuole formation and fusion as a mode of lumen formation in this system, 
FGF10/7/2, 7 days. The tell tale evidence of vacuole fusion are the “cytoplasmic humps” 
(arrows in right panel), which provide a silhouette of recently fused vacuoles. Spaces 
occupied by condensed nuclei cannot be mistaken for these fused vacuolar spaces, 
because the spatial distribution of apoptotic nuclei is not ordered, certainly not in the 
reproducible pattern of apparently fused vacuoles shown in these panels.  
 
5.6 “Fine Tuning” vascular network formation: mechanistic insights from the 
differences in vessel formation induced by FGF10/7/2 vs. SHH 
 
The current data clearly illustrate the differences in the morphology of endothelial 
networks formed by exogenous SHH vs. FGF10/7/2, with a marked decrease in 
secondary sprouting, in favor of lumen formation, endothelial attenuation and apparent 
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apoptosis of core cells upon SHH treatment (Figures 56 and 57). The core cell apoptosis 
feature is also observed prominently in FGF-treated constructs; however, the features of 
endothelial thinning and lumen formation are not as consistent in FGF-treated vessels. 
Still the question remains as to why these differences exist. In considering the tip cell 
morphology of endothelial tubules in SHH vs. FGF10/7/2, it is clear that filopodia 
formation, with the maintenance of a solid tip containing several viable endothelial nuclei 
is observed only in FGF10/7/2-induced vessels, while SHH-induced vessels, quite 
strikingly, almost completely lack filopodia and display attenuated endothelial 
morphology with lumen formation even in the very tip of nascent tubules (Figure 56). 
This observation suggests that SHH stimulates endothelial tubular morphogenesis via 
promotion of the morphological transition to an attenuated phenotype and promotion of 
apoptosis in core cells, perhaps along with accelerated vacuole formation/fusion 
processes, while events involving cytoskeletal and focal adhesion dynamics that lead to 
cell motility appear to be inhibited. Indeed, exogenous SHH protein at supra-
physiological levels was found to inhibit axonal extension in an in vitro model of neurite 
outgrowth, via apparent disruption of actin polymerization dynamics in growth cones, 
while physiological concentrations of SHH in the same experiments promoted axon 
extension (Trousse et al. 2001, Kolpak et al. 2005). 
 
The notion that exogenous SHH at supra-physiological levels feeds back negatively on 
the cytoskeletal processes associated with endothelial cell motility is further supported 
by the studies demonstrating increased activity of the protein Missing in Metastasis 
(MIM), which inhibits cell motility by inhibiting cortactin, which bundles actin filaments in 
filopodia, and also via binding of G-actin, inhibiting actin polymerization (Woodings et al. 
2003, Lin et al. 2005, Gonzalez-Quevedo et al. 2005). The MIM protein plays a separate 
role in stabilizing Gli-family transcription factor complexes (Callahan et al. 2004), which 
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involves SHH-mediated transcriptional events. The interaction of the SHH-responsive 
protein MIM with the cytoskeletal machinery represents an important mode of 
transcriptional independent action of SHH signaling, the nature of which would predict a 
loss of cell motility and inhibition of actin-mediated membrane dynamics with excessive 
levels of SHH signaling, as is likely the case at 500 ng/ml in our system.  
 
 
Figure 56: Comparison of morphologies in vessel tips of SHH-induced vs. FGF-induced 
vessels at 6 days, FGF10/7/2. Confocal images, description in text above. 
 
 
By contrast, FGF-2 signaling in endothelial cells in various contexts has been shown to 
promote angiogenesis via impacting cytoskeletal dynamics, viz. cell motility (Tsuda et al. 
2002, Kilarski et al. 2003). Extensive evidence of FGF-mediated promotion of the motile 
angiogenic phenotype in endothelial cells helps to explain the frequent observation of 
filopodia-studded angiogenic tubule tips in actively remodeling FGF10/7/2-induced 
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vascular networks. The role of Rac and actin dynamics in motility associated angiogenic 
events during network formation processes was illustrated in experiments with primary 
HUVECs and the in vitro Matrigel overlay assay (Connolly et al. 2002). Connolly et al. 
(2002) demonstrated that network formation in this assay occurs in 2 phases, the first 
phase involving initial morphological changes in the endothelial cells and coalescence 
into aggregates/cords, which at first lack a lumen, then the second phases involves 
migratory processes that mirror in vivo sprouting angiogenesis lead to an interconnected 
endothelial network with consistent lumen formation. Importantly, it was shown that 
disruption of actin polymerization dynamics, and separately inhibition of actin-myosin 
contraction of the cytoskeleton, blocked the second (motile) phase of network formation, 
but not the initial coalescence of the endothelial cells into aggregates/cords (Connolly et 
al. 2002). Interestingly, disruption of microtubule dynamics with Taxol blocked both 
phases of network formation. 
 
Still, there is not a clear explanation as to why the extremely thin, capillary-like 
morphology of endothelial cells in SHH-induced tubular networks are seen so frequently, 
while FGF10/7/2-induced tubular networks contain vessels with attenuated EC, however 
it is a much more spatially heterogeneous, with preference for thinning in areas in direct 
apposition to SHH-expressing epithelium (see Chapter 4, Figure<). The answer to that 
question may involve the differences in the endothelial basement membrane and 
surrounding matrix. In addition to the aforementioned morphological differences, the 
extracellular matrix on which the endothelial cells in FGF vs. SHH induced vessels is 
markedly different. First, there is an apparent (qualitative) increase in the ratio of laminin 
to tenascin in endothelial basement membranes (Figure 57), as indicated by less 
pronounced yellow coloration indicative of more evenly co-localized LM and TN-C 
observed in basement membranes of EC in FGF10/7/2 cultures (Figure 57). Secondly, 
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there is a marked decrease, and in many cases a complete lack of cytoplasmic 
localization of LM or TN-C in mesenchymal cells surrounding vessel cords and tips, and 
also absence of TN-C “frills” surrounding endothelial basement membranes in cord and 
tip cells (Figure 57). This suggests that perhaps FGF2 promotes a “matrix synthetic” 
state in the stromal and perivascular cells, which in combination with intracellular FGF-
mediated effects in motility, and also VEGF-A effects, gives rise to the filopodia-laden, 
apparently motile endothelial cells forming tips in FGF-induced vessels.  
 
 
Figure 57: Differences in TN-C composition of BM and surrounding matrix in SHH 
generated vessels vs. FGF generated vessels. Decreased numbers of, and lack of LM or 
TN-C staining in cytoplasm in, the surrounding cells is observed in the SHH-induced 
vessels; single confocal optical sections. 
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It is hypothesized that endothelial cells of SHH-induced tubules are in a different state of 
adhesion (more laminin integrin adhesions = stabilization) compared to FGF-induced 
tubules (more proteolysed BM, less laminin-integrin adhesions in favor of fibronectin or 
TN-C mediated adhesion), and that this difference in matrix interaction may account for 
the marked differences in endothelial tube morphology (Figure 57).  A secondary 
extension of this hypothesis is that the enhanced cell motility in FGF conditions vs. SHH 
conditions also promotes the coalescence of endothelial and perivascular cells, which 
certainly involves perivascular cell migration in response to chemotactic cues from the 
endothelial cells, or potentially vice-versa. 
 
In addition, the decreased prevalence of apoptotic nuclei and the maintenance of “solid” 
endothelial cords and tip-stalks containing multiple apparently viable endothelial nuclei 
(Figure 56, bottom panels) observed in FGF-induced networks may be related to 
increased activity of pro-survival signaling pathways, such as MAPK and Akt pathways, 
with exogenous FGF2. By contrast, the complete lack of any apparent viable internal 
endothelial cells in SHH-induced vessels, in favor of apoptotic cell death and 
cytoplasmic thinning of the cells lining the tubules (Figure 58), indicates that either SHH 
promotes selective endothelial apoptosis, or potentially that SHH signaling in the 
absence of ectopic FGF is not sufficient to activate prosurvival signaling pathways, such 
as MAPK and Akt pathways.  
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Figure 58: Distinct increases in consistency of lumen formation and apparent apoptosis 
(nuclear blebs) of cells on the interior of the lumen structure in SHH-induced vessels. 
Lumen formation occurs apparently independent of proximity to epithelial cells as 
indicated by the arrows in the right panel which show the gap between an apparent 
epithelial structure as inferred by nuclear morphology (outlined) and an SHH-induced 
vessel structure.  
 
 
5.7 Interrelationship of SHH and FGF signaling 
There are several studies in the literature which highlight the potential interrelationship of 
FGF signals and SHH signals in vascular development. The general consensus on the 
role of SHH in mesenchymal and vascular development is that of controlling the 
proliferation and angiogenic factor production of mesenchymal cells (White et al. 2006, 
Lavine et al. 2006), and particularly during embryonic development eliciting direct 
angiomorphogenic effects on SHH-responsive angioblasts (Vokes et al. 2004). The role 
of FGF2 signaling, which occurs preferentially in “c isoform” FGFRs of mesenchymal 
and endothelial cells, may have some overlapping roles in regulation of mesenchymal 
proliferation and vascular morphogenic events. It is also possible that the pathways 
potentiate one another. David Ornitz’s group has shown recently that coronary vessel 
development is dependent on a wave of SHH signaling that is potentiated by FGF9-
mediated upregulation of Ptc1 in the cardiomyocytes, which then leads to markedly 
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increased levels of VEGF and Angiopoietin production in the myocardium believed to 
stimulate the formation of the coronary vascular plexus. However, in the lung, it has 
recently been shown that FGF2 alone, and to greater degree in combination with 
Angiopoietin-1, is capable of rescuing pulmonary mesenchymal growth and vascular 
development in lung explant cultures from SHH-deficient mice (van Tuyl et al. 2006). 
This strongly suggests that there may be an independence of FGF signaling pathways 
and SHH in the regulation of pulmonary vascular development.  
 
The intracellular signaling pathways activated by SHH signaling and FGF2 signaling 
differ considerably, in terms of transcriptional-dependent effects, however both pathways 
also feedback on cytoskeletal substrates, perhaps in differing manners. As described in 
Chapter 1, FGF signals converge primarily on MAPK pathways in terms of altering gene 
transcription, while SHH signaling is mediated through the Gli-family factors on the 
transcriptional level. Importantly, FGF2 signaling is also believed to activate PI3K/Akt, 
promoting endothelial survival, and likely feeding back negatively on selective apoptotic 
processes. By contrast, SHH signaling is not known at the present time to activate these 
“endothelial survival” pathways. That being said, both pathways affect the focal adhesion 
and cytoskeletal dynamics in the cell, by altering the amounts and activity levels of key 
proteins involved in actin dynamics. In addition, FGF and SHH signals appear to 
differentially affect the apoptotic state of the endothelial cells, which, again, may reflect 
either differences in activities of prosurvival signaling pathways, or alternatively may 
represent a unique morphogenic signaling outcome elicited by SHH. The proposed 
model for differential action of SHH and FGFs is depicted diagrammatically in Figure 59 
below. 
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Figure 59: Schematic representation of the proposed roles of SHH and FGF2 in 
vascular morphogenesis, based on the findings of this thesis and known modes of 
action described in the literature. Details are discussed in the above text. 
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Chapter 6: Interfacing of pulmonary tissue constructs within a living animal 
 
 
6.1 Matrigel plug model --- Donor-derived Endothelial Cells Contribute to 
Functional Vascularization 
 
 
The central hypothesis of the in vivo studies in this thesis is that endothelial cells present 
within the donor FPC mixture would contribute to establishment of the vasculature in the 
constructs. This question was first addressed in our Matrigel plug model (Mondrinos et 
al. 2007b) when FPC pre-labeled with a cell tracer dye were used to generate in vivo 
pulmonary tissue constructs. In combination with FITC-dextran perfusion, cell tracing 
allowed for determination of whether donor-derived EC contribute to patent 
vascularization in vivo. Figure 60 illustrated that donor-derived EC are part of a 
functional vasculature in the constructs that assembles into and/or anastomoses with the 
host circulation (Figure 60B, arrows).  
 
 
Figure 60: Presence of donor-derived endothelial cells in patent vessels of in vivo 
implants. Taken from Mondrinos et al. 2007b. Fluorescent micrograph of paraffin section 
demonstrating the donor FPC identity (CellTracker, orange) of endothelial cells lining 
perfused blood vessels (FITC-dextran injection, green) in a Matrigel plug construct, see 
Mondrinos et al. 2007b attached as Appendix material for details. 
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6.2 Renal Capsule  
 
 
The central goal of the renal capsule implantation experiments was to demonstrate that 
in vitro generated, collagen gel-based constructs are capable of interfacing within a living 
host. Specific emphasis was placed on determining whether the vascular structures 
formed in vitro contribute to the establishment of a patent vascularization in vivo. There 
are fundamental difference between the methods of generating the constructs used for 
the in vitro studies described in Chapters 3-5 and those used for the renal capsule 
implants. This is due to the size and mechanical properties requirements for the surgical 
implantation. The constructs first need to be sufficiently small, less than 50 µl in total 
volume in order to fit comfortably under then capsule; and secondly, the constructs need 
to be sufficiently firm/stiff to allow for handling with forceps during the implantation 
without the construct falling apart. What this amounts to is the need to incorporate: 1 – 
serum, 2 – detached culture, and 3 – agitated culture on an orbital shaker; all of which 
are geared toward promoting gel contraction and enhancement of the mechanical 
properties. The idea to incorporate these tactics came from early experiments that 
demonstrated gel contraction in the detached gel configuration, a phenomena which was 
dramatically amplified with 10% FBS culture (Figure 61). 
 
Early in vitro experiments in collagen gels examining detached gel culture demonstrated 
poor epithelial branching, and thus this configuration was abandoned in favor of attached 
gel culture which retained gel volume and compliance, by inhibiting contraction. In 
experiments looking at 3-D monocultures of mammary epithelial cells in collagen gels, 
Streuli and Bissel (1990) demonstrated that gels which were “floated”, or detached from 
the mechanical connections to the culture plate, displayed higher levels of differentiated 
functions than “attached” gels, which is the primary configuration used in the 
experiments of this thesis. The general reason for enhanced differentiation in 3-D culture 
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was cited to be “flexibility” of the collagen gels, and not the biochemical response to the 
collagen type I, and this “flexibility” actually increases in floating gels, presumably due to 
release of the isometric tension experienced by the collagen fibers in the gel when 
attached to the culture dish. In our system, enhanced epithelial growth and branching is 
observed in attached gels, with the formation of small cystic AFUs in detached cultures, 
which contract markedly, such as those shown in Figure 61. In the experiments by 
Streuli and Bissel (1990), there were no stromal cells, and considering the lack of 
contractile activity in normal mammary epithelium, the collagen fibers in the gel are likely 
more compliant when detached and “free floating”, however in our system, detachment 
of the gel allows for mesenchymal cell-mediated gel contraction, and presumably as this 
contraction progresses the stiffness of the collagen fibers increases, at some point 
crossing a threshold that begins to feed back negatively on epithelial morphogenesis. 
Nevertheless, this method of culture is required to satisfy the basic mechanical 
requirements of the end product for surgical manipulation.  
 
 
Figure 61: Contraction behavior of detached gels cultured in vitro for 7 days. Digital 
photographs of detached gel cultures demonstrating gel contraction, particularly in the 
presence of 10 % serum. SF-ITS = 1% ITS, SF-GF = FGF10/7/2. 
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Having optimized the culture method to produce constructs with sufficient size and 
mechanical properties for physical manipulation in the renal capsule grafting procedure, 
implants were performed with constructs cultured in detached, agitated configuration for 
6 days in 5% FBS + FGF10/7/2; and these implants were maintained beneath the renal 
capsule for 5 days as described in Chapter 2. Histological analysis revealed the 
presence of ductal structures surrounded by red blood cell (RBC)-containing capillary 
structures, as well as a loose mesenchyme with numerous capillaries and apparently low 
levels of host infiltrate (Figure 62, left panel).  
 
     
Figure 62: H & E staining of renal capsule implants. showing the presence of red blood cell 
containing microvessels within a construct grown beneath the renal capsule for 5 days 
from the first successful experiment. Several microvessels are seen in the left panel 
(arrows), while the right panel depicts an individual microvascular lumen with contained 
red blood cells. 
 
 
 
Having confirmed that the procedure works and constructs with histiotypic lung 
architecture can be generated, the histology and differentiation of the input constructs 
following the 6 day in vitro culture period was assessed for purposes of comparison with 
what is recovered following 5 days of in vivo engraftment (11 total days from cell 
isolation). Histology of contracted constructs revealed the largely cystic nature of the 
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AFUs (Figure 63). Despite the lack of branching morphogenesis, the majority of cells in 
the cystic AFUs are proSpC+ (Figure 63, top right panel). This suggests that the mixture 
of 5% serum into the culture medium along with FGF-10/7/2 (for the purposes of 
contracting the gels) during the in vitro culture period does not alter the epithelial 
differentiation state observed in serum free FGF-10/7/2 cultures. Increase in gel stiffness 
which is associated with gel contraction apparently affects the morphogenic capacity, but 
not necessarily the cytodifferentiation of epithelial cells in the presence of FGF10/7/2. 
 
 
 
Figure 63: Histological analysis of the contracted construct pre-implantation. H & E 
staining demonstrates the largely circular, small AFU present within the constructs (top 
left and bottom left). Importantly the epithelial cells still appear to be well-differentiated, as 
indicated by proSpC staining (top right), and appear to be actively synthesizing 
pericellular matrices as evidenced by alcian blue staining for proteoglycans (blue, bottom 
right). 
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As described in Chapter 2, preliminary attempts at examining in vivo affects of 
FGF10/7/2 in the renal capsule model were carried out by flanking implanted constructs 
with FGF10/7/2-soaked sponges.  In describing these results and comparing them to 
controls without FGF sponges, the typical characteristics of constructs recovered 
following the 5 day in vivo culture period are described. Figure 64 illustrates that addition 
of FGF10/7/2-soaked sponges may perturb formation of a uniform vascular network. As 
can be seen in constructs alone (Figure 64, top panels), there is the formation of a fairly 
uniform and complex surface vascular network emerging from the perinephric fat. This 
differs markedly from constructs flanked with FGF10/7/2-soaked sponges, in which we 
observe the formation of much larger surface vessels which don’t branch significantly, 
but rather grow directly toward the FGF source (Figure 64, bottom panels).  
 
 
Figure 64: Gross analysis of surface vascularization in renal capsule implants. Top panels: 
formation of surface vessels emerging from the perinephric fat is prominent. Bottom 
panels: flanking of the constructs with FGF10/7/2 sponges apparently chemoattracts 
vessels emerging from the perinephric fat. 
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Histological and immunohistochemical analysis revealed marked differences in the 
internal microstructure of constructs generated with or without FGF sponges (Figures 65 
and 66). In constructs without exogenous FGF sponges, the largely cystic nature of 
AFUs observed following the in vitro culture period (Figure 63) is retained, however 
expression of proSpC by the glandular epithelial structures, as well as expression of 
VEGF-A in epithelium as well as mesenchyme is observed (Figure 65). 
 
 
 
Figure 65: Analysis of internal cellular structure, differentiation and vascularization of 
renal capsule grafts without FGF sponge addition. Top left: small, still circular (as in the 
input material, FigureV) AFUs localize proSpC, indicating maintenance of differentiation. 
Top right: taken from a different construct, from a different experiment, this image show 
VEGF-A localization in the epithelial cells lining the circular AFUs and in stromal cells. 
Bottom panels: taken from sections of the same construct stained for proSpC in the top 
left panel, H & E staining reveals robust interfacing of microvessels with AFUs.  
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We know from our in vitro analysis that cells of epithelial and mesenchymal origin 
express VEGF in our constructs. The observation that both glandular epithelial cells and 
interstitial cells express VEGF following in vivo implantation and growth (Figure 65, top 
right panel) is consistent with the notion above that the change in the culture conditions 
(addition of 5% serum, detachment to allow for contraction, mechanical conditioning) do 
not significantly alter the cytodifferentiation of the cells. The apparent high level of VEGF 
expression in the epithelium remains upon in vivo implantation, with very high 
localization of the cells in AFUs (Figure 65, top right panel), provides a potential 
mechanism for the phenomenon observed in which perfused vessels are juxtaposed to 
glandular epithelium (Figure 65, bottom panels).  This vessel juxtaposition is strikingly 
absent in constructs flanked with FGF sponges (Figure 66), apparently due to overriding 
vessel chemoattraction toward the exogenous FGF source as shown superficially in 
Figure 64.  
 
Interestingly, the FGF sponges do appear to enhance AFU growth, as indicated by 
enhanced AFU area (Figure 65 vs. 66, all magnifications same, 200x). Induction of 
histiotypic budding of AFUs is induced in proximity to FGF sponges, as shown in the top 
right panel of Figure 66 below. This finding indicates that exogenous FGFs positively 
regulate epithelial morphogenesis in vivo, similar to the in vitro findings, and that this 
occurs in a spatially dependent manner. If the angiogenic properties of the FGFs were to 
be used to enhance internal construct vascularization, microspheres or some other 
delivery vehicle that would allow for establishment of gradients with the highest 
concentration at the construct center will be required. The observation that vessel 
juxtaposition with AFUs occurs without exogenous FGFs, but is blocked by in their 
presence, suggests that perhaps engineering epithelial cells that over-express 
angiogenic factors would be a better strategy to facilitate epithelial-endothelial 
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interfacing. Taken together, the findings illustrate that careful optimization of both 
exogenous and endogenous growth factor elaboration will be required to “fine tune” in 
vivo vascularization of pulmonary tissue constructs with a delicate balance between 
exogenous factors promoting vessel development and also inhibiting/overriding 
endogenous patterning cues.  
 
 
Figure 66: Analysis of internal cellular structure, differentiation and vascularization of 
renal capsule grafts with FGF sponge addition. Top left: larger, more dilated AFUs, with 
apparent small budding behaviors localize proSpC robustly, indicating maintenance of 
differentiation (image from construct center). Top right: taken from the same construct, 
this image shows formation of apparent epithelial and endothelial basement membranes 
with laminin staining. Bottom panels: taken from sections of the same construct, H & E 
staining reveals a striking lack of microvessels with AFUs in the construct center (bottom 
left) and also adjacent to the sponge (bottom right), which appears to chemoattract the 
vessels away from the AFUs.  
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As was described for the Matrigel plug experiments (Mondrinos et al. 2007b) and shown 
in Figure 60, determining the contribution of donor-derived vascular structures to 
establishment of patent vascularization in vivo is a central goal of our in vivo studies. We 
performed experiments using GFP host animals in which numerous GFP-negative, 
perfused vascular structures were observed (Figure 67), suggesting that these 
structures are donor-derived. As a caveat, the mice are GFP hemizygous, therefore a 
mosaic transgene expression pattern is expected without all host cells being GFP-
positive, therefore lack of GFP expression is not an absolute determinant of graft origin. 
We also performed experiments with cell tracer dye labeled cells, similar to Figure 60, 
which demonstrated red blood cell-containing vessel lumens lined by cell tracer positive 
endothelial cells of donor origin (not shown here). In Figure 67 (top panel arrow and 
bottom panels), GFP-positive, perfused vessels of host origin are observed, suggesting 
that the patent vasculature present within the constructs is chimeric, composed of both 
donor-derived and host endothelial cells.  
 
From a tissue engineering perspective, it would be invaluable to generate tissue 
constructs containing a primitive vascular network capable of anastomosis with host 
circulation upon implantation. This approach has been investigated recently in studies 
aimed at generation of skeletal muscle constructs containing in vitro engineered vascular 
networks (Levenberg et al. 2005). “Pre-vascularized” skeletal muscle tissue constructs 
demonstrated engraftment with host vessels, dramatically enhancing construct 
integration and viability in vivo (Levenberg et al. 2005). The results of our renal capsule 
experiments (Figure 67) suggest that this approach is possible in engineering lung 
tissues as well.  
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Figure 67: Characterization of donor vs. host origin of patent vasculature within renal 
capsule implants. In this image (top panel) GFP host and TRITC-dextran perfusion are 
used track blood flow and host cells. Several large, perfused vessels that are not 
comprised of GFP+ endothelial cells are observed (hemizygous host caveat in mind). In 
addition, we observed TRITC-dextran perfused vessels of host origin comprised of GFP+ 
endothelial cells (bottom panels, arrow in top panel).  
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Chapter 7: Special Topics 
 
7.1 Heterogeneity in the System 
 
As described in Chapter 2, E17.5 murine fetal pulmonary cells (FPC) are isolated by 
tissue mincing and enzymatic digestion in a simple trypsin solution. An important issue 
that should be mentioned in the beginning of describing the characterization of this 
system is that the precise gestational time at which the fetuses are isolated from the 
mother can not be known. Therefore, E17.5 is an approximation.  In our experience, 
from week to week there is sometimes considerable variation in the apparent age of the 
fetuses obtained, based on subjective assessments such as fetus size/proportions and 
calcification of bones in ribs/limbs that can be felt when dissecting. It would not be 
surprising if it varied as much as 1 day in each direction, with fetuses as young as E16.5 
in some cases and as old as E18.5 in other instances.  There is variation in both 
directions, with some litters of fetuses seeming older (larger size, more calcified rib 
cages and limbs), as well as some litters seeming younger, with sometimes dauntingly 
small size and distinctly more underdeveloped thoracic bone and organ structures. This 
variation is likely due to the inaccuracy of current assessment methods of precise time of 
fertilization (even in commercial setting, the vaginal plug is the most common), which 
require assumptions based on secondary observation that sexual activity occurred 
between the breeding pair (Jackson Labs, Online Technical Information).  
 
A hugely important biological implication of this variation in age range of isolates used is 
the state of flux in distal vasculogenesis at the times in question, with endothelial cells 
isolated 0.5 days either way from E17.5 certainly having differing “vasculogenic states”. 
These variations in primary fetal cell isolates certainly contribute to the “biological 
heterogeneity” observed in these kinds of systems, which have likely steered many 
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investigators away from trying to further develop organotypic cultures. The point of this 
discussion is to try to move toward understanding the likely reasons for some of the 
variations in biological responses observed.  For example, the phenomenon that in 
general the relative differences in EC network formation across conditions are 
reproducible, but the magnitude and rate of EC network formation varies markedly for a 
certain condition in independent experiments. It is this heterogeneity that necessitates 
the normalization of data to an internal control (usually 1% ITS medium with no 
exogenous supplements) ran in each experiment, and the representation of the data as 
fold increase across conditions. 
 
7.2 Synthetic polymer scaffolds --- hurdles to overcome in Tissue Engineering 
 
The ability to engineer a scaffold that provides architecture and the possibility of 
controlled release of morphogenic signals in a spatially and temporally controlled 
manner would be valuable for recapitulating lung development. In addition, the ability to 
fabricate precise pore geometries in combination with computer-aided design 
(Mondrinos et al. 2006b) may in the future allow for the fabrication of lung scaffolds with 
tubular pore systems similar to airways. However, before those advantages can be 
realized, several major obstacles need to be overcome. In very early studies carried out 
in parallel with Matrigel the early experiments, the use of synthetic polymer scaffolds 
was investigated. Histological analysis of Hematoxylin and Eosin staining of fetal 
pulmonary cells cultured for 2 weeks on these synthetic scaffolds demonstrated cellular 
infiltration of both the fibrous matrices and porous sponges, albeit to different degrees 
(Mondrinos et al. 2006a). AE2 differentiation was found to be deficient in synthetic 
scaffolds, as assessed by TEM and RT-PCR of the SpC gene. TEM analysis revealed a 
lack of lamellar bodies and tubular myelin, viz. the surfactant packaging and secretion 
machinery. In both scaffolds tested (PLGA foam and PLLA fibers), while there are no 
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epithelial cells, there is robust mesenchymal cell proliferation. These findings illustrate 
the inherent competitive advantage that the mesenchymal cells have in the setting of a 
mixed in vitro culture, which is apparently exploited when cells are cultured in 2-D at low 
density and in 3-D polymer scaffolds which are not nearly as rigid at TCPS, but still far 
more rigid than soft tissue. In the case of synthetic scaffolds, even the addition of tissue-
specific growth factors to the medium did not overcome the lack of epithelial 
differentiation. Perhaps the development of hybrid biomaterials (Li et al. 2006) with 
enhanced biochemical recognition sequences, degradation byproducts and mechanical 
properties (compliance) will allow for incorporation of more “engineerable” materials into 
scaffold designs for lung tissue engineering. For now, much can be learned using simple 
model extracellular matrix gels, such as Matrigel and type I collagen, while waiting for 
our understanding of cell-biomaterial interactions to catch up to our fabrication 
technologies. 
 
7.3 Extensions to Pulmonary Medicine 
 
Being that the lung is one of the most complex organs in the body with specific 
architecture and cellular differentiation required to achieve physiological function, it 
represents a daunting tissue engineering problem. There has been much work tissue 
engineering of proximal airway equivalents (Choe et al. 2006), however only recently 
have some attempts, including our own, at in vitro generation of distal lung (alveolar) 
structures have been reported (Cortiella et al. 2006, Chen et al. 2005, Mondrinos et al. 
2006a). The focus has been mostly on generating the alveolar epithelium from stem 
cells (Ali et al. 2002, Samadikuchaksaraei et al. 2006) and culturing lung epithelial cells 
in 3-D (Lin et al. 2006). While others have focused on mesenchymal cells in 3-D fetal 
pulmonary cell cultures, this work begins to move beyond other attempts at engineering 
distal lung tissue by focusing on organotypic epithelial-mesenchymal-endothelial 
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interactions (Mondrinos et al. 2007a). Using the FPC model, this thesis has gathered 
significant information on matrix and growth factor requirements for in vitro assembly of 
lung tissue. From a translational perspective, it is not a viable strategy to isolate cells of 
appropriate gestational age from human fetal lung tissue, since there is currently no 
source of this tissue. As in many other tissue engineering and regenerative medicine 
problems, cell sourcing is an issue in pulmonary tissue engineering. Therefore, there is 
much work underway in the area of stem cell differentiation toward pulmonary lineages, 
with reports of adult stem cells derived from bone marrow (Kotton et al. 2001), cord 
blood stem cells (Berger et al. 2006), and perhaps the most promising results with 
embryonic stem cells (Ali et al. 2002, Samadikuchaksaraei et al. 2006). Though the field 
is not there yet, studies with FPC will continue to reveal appropriate combinations of 3-D 
matrices and soluble factors that facilitate lung morphogenesis, which will hopefully 
extrapolate to equivalent populations of mesodermal and endodermal cells eventually 
derived from stem cells.  
 
In terms of eventually implanting engineered lung constructs into the lung parenchyma, 
there are some important considerations regarding interfacing of tissue components. It is 
known that embryonic distal lung vasculature anastomoses with the central circulation, 
and this behavior has been demonstrated in embryonic lung allografts in the renal 
capsule (Zhao et al. 2005), and also is observed in our renal capsule grafts (Chapter 6). 
Therefore, it is reasonable to assume that vasculature engineered within pulmonary 
tissue constructs will interface with the recipient. By contrast, epithelial structures 
present within such “random-seeded” gel constructs, epithelial structures (AFUs) form 
separately, thus not generating a contiguous network similar in nature to the respiratory 
epithelial tree found in vivo. Since these structures do not form a continuous network, 
and since a fusion of epithelial tubules is not a known morphogenic behavior in vivo, it is 
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not obvious how AFUs present within constructs such as those engineered in these 
studies will be able to integrate into the respiratory tree. Future attempts at tissue 
engineering lung constructs for replacement of distal lung will require the development of 
3-D scaffolds which contain a continuous closed epithelial conduit of decreasing 
diameter down to alveolar structures, the proximal end of which can be sutured to a 
sufficiently large terminal airway. Another potential strategy is to engineer constructs 
devoid of an epithelium, which contain a mesenchyme of the appropriate distal lung 
phenotype and a vascular network, which could provide a new “field” of tissue for 
existing airways to continue to branch and grow. Other approaches such as intratracheal 
administration of cells may have more immediate potential for clinical applications 
(Crisanti et al. 2007). Therefore, in the short term, constructs such as those generated in 
these studies will likely contribute to pulmonary medicine by providing novel venues for 
the study of the lung developmental and pathobiological processes in a controlled in vitro 
system which achieves physiological relevance. 
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Fetal Pulmonary Cell Isolation and In Vitro Culture 
Preparation of Dissociated E17/18 Murine Fetal Pulmonary Cells 
 
Note: This protocol has been used for the isolation of E16-18 lung cells. At this stage, 
trypsin is sufficient to dissociate the epithelium into small aggregates. In our hands older 
fetuses and neonatal lungs dissociated using this protocol produce virtually no 
epithelium post-filtration. It is important to note that although this protocol has suited our 
needs for 3+ years, it is by no means a totally optimized protocol, and could possibly be 
improved by using combinations of other enzymes (collagenases, dispase), however we 
consistently used this simplified protocol. 
 
1. Sacrifice the pregnant mothers and transfer the pups into a clean Petri dish. This 
is typically done on the benchtop. However, be sure to use a clean Petri dish and 
spray alcohol on the outside and transfer the fetuses quickly. 
 
2. Transfer the dishes containing dissected fetuses to the cell culture hood. All 
steps from this point forward are performed under aseptic conditions. 
 
3. Overlay the fetuses with pre-warmed Hank’s balanced salt solution (HBSS). 
 
4. Dissect the lungs from the individual fetuses by pinning them down to cardboard 
or foam using pins or syringe tips. Make a thin thoracic slit and gently remove the 
lungs from the chest using a good pair of forceps. Often the lungs come out with 
the heart attached, so take care to remove the hearts. Transfer the fetal lungs to 
a small Petri dish containing HBSS. 
 
5. After dissecting all the fetal lungs, check the dish for the presence of non-lung 
tissue fragments, usually liver or heart. Note: At this point, further dissection of 
the tissue, i.e. only taking distal tips, etc. may be done. In our case for the E18 
cells, we use the entire lung. Mince the lungs thoroughly with a disposable 
scalpel. The lungs should appear as a puree before moving to enzymatic 
dissociation. 
 
6. Add trypsin-EDTA (0.25-0.5 % trypsin concentration we have used from the 
concentrate from Sigma, but any trypsin would do) and triturate briefly using a 
Pasteur pipette with a bulb. The volume used varies depending on number of 
lungs, generally 2-3 ml per litter (7-10 pups), so for 5 litters (50 pups or so), it 
would be around 12-15 ml of trypsin in a small dish. 
 
7. Transfer to the incubator for 20-25 minutes. 
 
8. Remove and briefly triturate in the trypsin (optional if the tissue does not look 
adequately digested, and can then be returned to the incubator for additional 5 
minute increments, with trituration between steps). 
 
9. Add pre-warmed DMEM containing 10% FBS to quench the trypsin activity.  
 
10. Triturate vigorously for ~ 3 minutes in order to dissociate loosely connected 
tissue fragments and monodispersed cells. 
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11. Filter the resultant suspension through a 70 micron mesh, using the plunger of a 
3 ml syringe to force smaller aggregates through the mesh, by using it as a 
piston, washing the filter continuously. You will wind up with a lot of mushy tissue 
fragments that do not make it through the filter, however by washing and using 
the piston technique you can “force” sufficiently small aggregates of dissociated 
epithelium through the filter, which is necessary because otherwise they simply 
get caught up in the sticky mess on the filter. You will have to switch to a fresh 
filter a few times if doing multiple litters (usually 2-3 filters for a 5 litter 
preparation). 
 
12. Centrifuge the filtered suspension for 5 minutes at 800 rpm. 
 
13. Resuspend the pellet in 900 µl of distilled water (have a P200 pre-loaded with 
100 µl of 10X PBS) in order to lyse red blood cells for 30 seconds. Add 100 µl of 
10X PBS exactly at 30 seconds to restore osmotic balance. WARNING: this step 
is very delicate and cannot go beyond 45 seconds before adding the 10X PBS at 
risk of lysing all the cells, not just the RBC. 
 
14. Again centrifuge the suspension (the resultant pellet should no longer appear 
red) and then resuspend in a desired volume and count using trypan blue to 
assess viability. If the digestion has worked properly, there should be abundant 
small aggregates of dissociated epithelium; if there are only single cells visible 
during counting, then it is likely a low epithelial yield was obtained. This does not 
preclude doing an experiment; it just makes the culture less “organotypic”, with 
the preparation consisting mostly of mixed mesenchymal and endothelial cells. 
 
15. Cells are now ready to be suspended in hydrogels at desired cell densities or for 
whatever desired application---at this time any manipulations of the cells, i.e. 
tracker labeling, siRNA, etc. may be done, preferably as rapidly as possible. We 
have found that the cells do very poorly if plated in 2-D then re-harvested to put 
into 3-D culture, therefore any manipulations intended for cells to be cultured in 
3-D should be done immediately post-isolation and any protocols modified to 
accommodate cells in suspension. 
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Preparation of collagen gel constructs and culture under “optimized” conditions  
 
Prepare solution of collagen (BD Biosciences, collagen type I from rat rail) at the desired 
concentration. Typically a 1.0-1.2 mg/ml final collagen concentration was used for cell 
culture experiments. This is done per manufacturer’s protocol and basically restores the 
collagen solution to physiological osmolarity and pH.   
 
1. Determine the density of fetal pulmonary cells that you want to seed in the gels. 
Typically, we use between 2.5-5.0 x 106 FPC/ml collagen gel solution, depending 
on the cell yield and the desired number of experimental conditions/replicates. 
Using much lower (< 1 x 106) or higher (> 10 x 106) will alter experiments 
considerably due to different  levels of paracrine factors, as well as nutritional 
requirements with varying densities of cells. 
 
2. Resuspend disaggregated lung cells in small volume of collagen (500 µl - 1000 
µl) solution initially using a 1000 µl pipette. Be sure to put the pellet on ice briefly 
prior to this step to ensure that the collagen does not begin to polymerize when 
contacting a warm cell pellet. 
 
3. Determine then the volume and number of constructs that you would like to 
make. This will vary depending on the yield and may need to be changed to 
accommodate a certain number of desired samples. Typically we use 24 well 
plates, but we have used 48 well plates as well. For the 24 well plates, use 
between 0.5-1.0 ml, for 48 well plates 0.3-0.5 ml, depending on if you want a 
relatively thin or thick gel.  
 
4. Pipette the collagen-fetal pulmonary cell suspension into the well plates and 
quickly transfer to the incubator. This step should be done as quickly as possible, 
but it has been impossible in our hands to eliminate settling of the larger 
aggregates (the epithelial cells) into the lower region of the gel.  Serendipitously, 
this turns out to be useful since when stained as a whole mount, most of the 
vascularized epithelial units are located in the lower several hundred microns of 
the gel and when the sample is inverted and mounted on a slide these structures 
are easily imaged in 3-D using a laser scanning confocal microscope. The upper 
region of the gel has a much lower cellular density and is composed mostly of 
sparse mesenchymal cells and individual endothelial cells, however is essential 
to provide support, meaning resistance to contraction, which has correlated 
poorly with morphogenesis in our hands. 
 
5. Following 15-20 minutes, the gel should polymerize completely. This is apparent 
because the gels become more opaque when solidified, and can be confirmed by 
tilting the plate. At this point the gels are adhered to the plastic in the well plate. 
Add 50:50 F12/DMEM + 10% FBS to the constructs (2 ml media for 24 well 
cultures, 1 ml media for 48 well cultures) and incubate overnight. This step is 
included to help the cells overcome the stress of the isolation, however we have 
omitted this step without apparent loss of cell viability, for example in 
experiments where addition of inhibitors to the gel/medium from the beginning is 
desired, i.e. no media change the following morning. 
 
6. The following morning remove the media and replace with serum-free, growth 
factor defined medium: 50:50 F12/DMEM + 1% ITS supplement (BD), 25 U/ml 
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heparin, rhFGF-10 (25 ng/ml), rhFGF-7 (10 ng/ml), rhFGF-2 (12.5 ng/ml); all the 
FGFs are from Sigma. This is what we call the “optimized” medium, but it is by no 
means the magic bullet, there are likely other factors that could enhance 
growth/differentiation of the various cell lineages present, however we have 
hypothesized that the FGFs are essential to epithelial growth/differentiation and 
that well differentiated, growing/branching epithelium would help to orchestrate 
overall construct morphogenesis, i.e. vascularization. 
 
7. The gels are easily monitored over time using the phase contrast microscope. 
The gels are densely cellular, so it is hard to make out fine structures like thin EC 
tubes; however growth of epithelial aggregates is grossly observable in phase 
contrast. 
 
8. The nutritional depletion of the media may be monitored by color, but typically at 
the densities we use, the media is replaced every 48 hours during the first week 
of culture, then every 24-36 hours in extended culture as the cell numbers in the 
gels increase. 
 
9. Gels may then be processed for various analyses similarly to tissues.  
 
  
 
